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Chromatin remodeling accompanies differentiation,
however, its role in self-renewal is less well under-
stood. We report that in Drosophila, the chromatin
remodeler Kismet/CHD7/CHD8 limits intestinal
stem cell (ISC) number and proliferation without
affecting differentiation. Stem-cell-specific whole-
genome profiling of Kismet revealed its enrichment
at transcriptionally active regions bound by RNA po-
lymerase II and Brahma, its recruitment to the tran-
scription start site of activated genes and develop-
mental enhancers and its depletion from regions
bound by Polycomb, Histone H1, and heterochro-
matin Protein 1. We demonstrate that the Trithorax-
related/MLL3/4 chromatin modifier regulates ISC
proliferation, colocalizes extensively with Kismet
throughout the ISC genome, and co-regulates genes
in ISCs, including Cbl, a negative regulator of
Epidermal Growth Factor Receptor (EGFR). Loss of
kismet or trr leads to elevated levels of EGFR protein
and signaling, thereby promoting ISC self-renewal.
We propose that Kismet with Trr establishes a chro-
matin state that limits EGFR proliferative signaling,
preventing tumor-like stem cell overgrowths.
INTRODUCTION
Regulation of stem cell proliferation rates is critical in adult
tissues, which need tomaintain basal renewal and undergo dam-
age-induced regenerative responses. Consequently, the dysre-
gulation of stem cell proliferation can have pathological effects.
Ample evidence now supports a functional link between the de-
regulated proliferation of stem cells and cancer initiation, as well556 Developmental Cell 49, 556–573, May 20, 2019 ª 2019 The Auth
This is an open access article under the CC BY license (http://creativeas metastatic progression (de Sousa e Melo et al., 2017; Flava-
han et al., 2017). Interestingly, the loss of epigenetic control is
a major contributor to stem cell misregulation including prolifer-
ation deregulation during aging (Brunet and Rando, 2017;
Challen et al., 2014; Ko et al., 2011). Therefore, in addition to
roles of epigenetic regulation during differentiation of stem-
cell-derived lineages, chromatin modulation also has important,
though not yet well understood, roles in the control of stem cell
proliferation.
A useful model to investigate adult stem cell regulation is the
Drosophila midgut, which is maintained by around 1,000 multi-
potent intestinal stem cells (ISCs). Most ISC divisions lead to
asymmetric daughter cell fates, resulting in a self-renewed ISC
and a sister enteroblast (EB) cell (Figure 1A). A majority of EBs
receive high levels of Notch signaling and differentiate into enter-
ocyte cells (ECs). Rare stem cell divisions produce an enteroen-
docrine precursor cell (EEP) with low or no Notch signaling,
which is thought to divide once to make two enteroendocrine
cells (EEs) (Chen et al., 2018; Ohlstein and Spradling, 2007; Salle´
et al., 2017). In response to epithelial damage, several signaling
pathways become activated and coordinate ISC proliferation
and differentiation (see for review, Jiang et al., 2016). Of primary
importance are signals that the ISCs receive to activate the Jak/
Stat and Epidermal Growth Factor Receptor (EGFR) pathways
(Biteau and Jasper, 2011; Buchon et al., 2010, 2009; Jiang
et al., 2011, 2009; Wang et al., 2014; Xu et al., 2011). Moreover,
other pathways such as Insulin, Hippo, Jun Kinase, BMP, Wnt,
and Hedgehog also control ISC proliferation (Biteau et al.,
2008; Cordero et al., 2012; Li et al., 2013, 2014; Lin et al.,
2008; O’Brien et al., 2011; Ren et al., 2010; Shaw et al., 2010;
Staley and Irvine, 2010; Tian and Jiang, 2014; Tian et al., 2015,
2017). Evidence suggests that there are alsomechanisms to limit
ISC responsiveness, tuning down cell division when sufficient
renewal has occurred (Guo et al., 2013; Hochmuth et al.,
2011), though this process is not well understood.
Here, we report on the identification of a regulator that is
essential to limit ISC proliferation: kismet, similar to theor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. Loss of kismet Provokes ISC Accumulation without Affecting Terminal Differentiation
(A) The ISCs divide to self-renew and to produce a precursor cell, the EB, that subsequently terminally differentiates into an EC or is thought to divide once as an
EEP to produce two EE cells.
(legend continued on next page)
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chromodomain-containing chromatin remodeling factors CHD7
and CHD8. Mammalian CHD7 is associated with transcription-
ally active genes at enhancers, super-enhancers, and promoters
where it can both activate and repress transcription (Hnisz et al.,
2013; Schnetz et al., 2009, 2010). kismetwas originally identified
as a ‘‘trithorax group’’ gene because of its ability to dominantly
suppress Polycombmutant phenotypes (Kennison and Tamkun,
1988). Studies using the polytene chromosomes of the salivary
gland have shown that Kismet is associated with transcription-
ally active chromatin, where it recruits the histone methyl trans-
ferases Trithorax and Ash1. Ash1 recruitment, in turn, is thought
to promote H3K36me2, leading to the inhibition of Histone
H3K27me3 (Dorighi and Tamkun, 2013). In addition, as kismet
mutants show a reduction in elongating RNA polymerase II
(RNA Pol II), Kismet was proposed to promote transcription elon-
gation (Srinivasan et al., 2008). Whether Kismet acts in other tis-
sues via similar molecular effectors is not currently known.
CHD7/CHD8 and Kismet have essential functions during
development and in adult tissues. In humans, inactivation of
CHD7 causes a spectrum of congenital defects called CHARGE
syndrome, (Coloboma, Heart defects, Atsresia choanae,
Retarded growth and development, Genital abnormalities and
Ear anomalies) (Bajpai et al., 2010; Vissers et al., 2004). More-
over, CHD7 is essential for neural development and adult neural
stem cell maintenance and is deregulated in cancers (Feng et al.,
2013, 2017; Jones et al., 2015; Pleasance et al., 2010; Robinson
et al., 2012).CHD8mutations are associated with neurodevelop-
mental defects in autism spectrum disorders (Neale et al., 2012;
O’Roak et al., 2012; Talkowski et al., 2012). InDrosophila, kismet
mutants have defects in developmental patterning with homeo-
tic transformations as well as alteration of circadian rhythm and
memory (Daubresse et al., 1999; Dubruille et al., 2009; Meli-
charek et al., 2010; Terriente-Fe´lix et al., 2010, 2011). However,
to date, functions of kismet in stem cells have not been
described.
Here, we demonstrate that Kismet is an important regulator of
ISCs, essential to limit basal levels of ISC proliferation. DNA
adenine methyltransferase identification sequencing (DamID-
seq) of Kismet compared with DamID reporters of different chro-
matin states, including activated (Brahma and RNA Pol II) and
repressed states (Polycomb, Histone H1, Heterochromatin Pro-
tein 1 [HP1]), demonstrated that Kismet preferentially localized to
transcriptionally active regions of the genome and to develop-
mental enhancers. In addition, our data suggest that Kismet
acts in ISCs with the H3K4 monomethyltransferase, Trithorax-
related complex (Trr; mammalian MLL3/4). We find that Trr and
Kismet co-localize in the genome and co-regulate the transcrip-
tion of many genes, including Cbl, a negative regulator of EGFR(B and C) Wild-type (B) and kis10D26 mutant (C) MARCM clones, 5 days after hea
(D) Quantification of (B) and (C).
(E) Scheme of wild-type and kismet mutant clones.
(F) Scheme of kismet gene andKismet protein (Long and short isoforms: Kis L and
alleles resulted in nonsense mutations: nucleotide changes and corresponding p
(G–L) Wild-type and kis10D26 MARCM clones at 9 days AHS. Arrows in (G)–(H0) a
(M–P) Quantification of the total cells per clone (M), number of EE cells per clone
(Prospero+ cells / EC (polyploid nucleus >7 mm) per clone (P).
(Q and R) Vertical sections through the midgut epithelium of control (Q) and kis10
In (D) and (M)–(P), A two-tailed Mann-Whitney statistical test was used; mean valu
bars, 20 mm.
558 Developmental Cell 49, 556–573, May 20, 2019signaling. Our data therefore demonstrate that the chromatin
regulators Kismet/CHD7/CHD8 and Trr complex/MLL3/4 func-
tion together to limit basal levels of ISC proliferation and identify
Cbl as a key downstream target gene allowing control of EGFR
signaling.
RESULTS
Identification of kismet as an Essential Gene Controlling
Stem Cell Homeostasis
We screened for EMS-induced mutations affecting ISC activity
and intestinal homeostasis (C.P., F.S., and A.B., unpublished
data) and found one line (10D26) that showed an increase in
the size of mutant clones generated in the midgut of adult flies
(Figures 1B and 1C) and had a higher proportion of cells express-
ing Delta, an ISC marker (8.9 Delta+ cells; 44% of clone) when
compared to the control (1.6 Delta+ cells, 20% of clone;
Figure 1D). In addition, these cells expressed the ISC marker
Sanpodo (Perdigoto et al., 2011) (Figures S1A and S1B). There-
fore, 10D26 mutant clones induce aberrant accumulation of
stem cells (Figure 1E).
Deficiency mapping followed by failure to complement
three known alleles of the kismet gene (kismet1, kismetEC1, and
kismetLM27) indicated that 10D26 harbored a lethal mutation in
kismet. kismet encodes a conserved chromatin remodeling
factor, similar to CHD7 and CHD8 in mammals. kismet encodes
a long (Kismet-L) and short (Kismet-S) isoform, with only
Kismet-L containing two chromodomains and an SNF2-like
ATPase/helicase domain, required for nucleosome remodeling
activity (Bouazoune and Kingston, 2012) (Figure 1F). All four
alleles correspond to nonsense mutations early in kismet-L
coding sequence (Figure 1F). Clones for kismetEC1, kismetLM27,
and kismet1 reproduced kismet10D26 phenotypes (Figures S1C,
S1D, S1O, S1Q, S1S, S1U, and S1V). No phenotype was
observed outside of clones, arguing against dominant-negative
action of truncated proteins (Figures 1C, S1D, S1O, S1Q, and
S1S). kismet10D26 phenotypes were rescued by a transgenic
BAC construct (kislocus) encompassing the genomic locus con-
taining kismet fused to a FLAP tag-encoding sequence (STAR
Methods; Figures S1C–S1F). In addition, the expression of
kismet-L cDNA, rescued clone size and increased stem cell
number phenotypes of kismet10D26, kismetEC1, kismetLM27, and
kismet1 alleles (Figures S1G, S1H, and S1M–S1V). In contrast,
kismet-S cDNA expression did not rescue kismet10D26 pheno-
types (Figures S1I, S1J, S1M, and S1N). Therefore, we conclude
that kismet-L is required for normal midgut homeostasis. We
will henceforth refer to kismet-L as ‘‘kismet.’’ Interestingly,
the overexpression of an ATPase-dead version (KismetK2060R)t shock (AHS).
Kis S): chromodomains (green), ATPase domain (red), BRK domain (blue). All kis
utative resulting truncated proteins are shown.
nd (I)–(J0) show EE cells marked by DH31 or LTK2, respectively.
(Prospero+) (N), number of ECs (Pdm1+ cells per clone) (O), and the ratio of EE
D26 mutant (R) MARCM clones, 9 days AHS. Arrows show apical membrane.
es in red; error bars, SEM; ns = non-significant, **p < 0.01, ****p < 0.0001. Scale
Figure 2. Loss of kismet Activity Promotes ISC Proliferation
(A and B) Wild-type (A) and kis10D26 (B), MARCM clones at 30 days AHS.
(C and D) Quantification of the percent of clones with at least one PH3+ cell (C) and the average number of PH3+ cell per clone (D) from (E)–(F0).
(legend continued on next page)
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also showed a partial rescue of the mutant phenotype (Figures
S1K–S1N). These data suggest that additional functional
domains of Kismet are important for stem cell regulation,
possibly by bridging interactions with other factors.
We then asked whether terminal differentiation was affected
by the loss of kismet. kismetmutant clones, like wild-type clones,
were able to produce terminally differentiated EC (Pdm1) and
EE cells (Pros), though they made more per clone, consistent
with larger clone sizes (Figures 1G–1P). Additional markers for
differentiated EEs (peptide hormones DH31 and LTK2) and
ECs (apical brush border) were detected in kismet mutants (Fig-
ures 1G–1J0, 1Q, and 1R). Thus, we conclude that loss of kismet
function in ISCs results in increased stem cell numbers, without
major defects in terminal differentiation.Kismet Activity Limits Proliferation and Self-Renewal
of the ISC
We then hypothesized that an increase in ISC numbers could be
due to altered proliferation. Consistent with this, at 30 days after
heat shock (AHS), kismet mutant tissue took over most of the
midgut (Figures 2A and 2B), suggesting that mutant clones
have a growth advantage over both heterozygous and wild-
type cells.
Since ISCs are the primary dividing cell type in the midgut, we
then assessed ISC proliferation using phospho-Histone H3 (PH3)
as a marker for mitotic cells. 7.6% of the control clones had at
least one and never more than one mitotic cell per clone (Figures
2C–2E0). In contrast, 21.4% of kismetmutant clones had at least
onemitotic cell, and clones with more than one dividing cell were
detected (Figures 2C, 2D, 2F, and 2F0). We assessed cell cycle
parameters using the Fly-FUCCI system (Zielke et al., 2014)
and found that kismet mutants had an increased proportion of
ISCs in S phase and G2/early M at the expense of the G1 fraction
(Figures 2G–2I). Together, these data further support the idea
that kismet mutant ISCs have deregulated proliferation.Kismet Controls Cell Division in a Stem-Cell-
Autonomous Manner
To determine in which cell kismet activity is required, we first
assessed its expression profile in the intestine. An antibody
recognizing the C-terminal part shared by the short and long
forms of Kismet showed enrichment in cells positive for Escargot
(esg), amarker of ISCs and EBs, and in EE cells compared to ECs
(Figures 2J–2K0). To test cell-type-specific requirements of
kismet, we verified that expressing kismet RNAi constructs(E–F0 ) Wild-type (E and E0), and kis10D26 (F and F0 ), 9 days AHS MARCM clones (
(G and H) Wild-type (G) and kis10D26 (H), MARCM clones 9 days AHS expressing
stage determination (G1, nuclear GFP+; S: RFP+; and G2/M, GFP+ and RFP+; a
(I) Quantification of the percent ISCs (from G and H).
(J) Mean Kismet fluorescence intensity normalized by mean DAPI staining in ISC
(K and K0) Kismet showed ubiquitous nuclear expression with a stronger accum
(diploid GFP).
(L and L0) kismet RNAi-expressing clones, 9 days AHS, had depleted Kismet pro
(M and N) Quantification of the number of cells per clone (M) and ISCs (Delta+) p
(O–Q) ISC-specific expression of GFP alone (O) or with kis RNAi BL36597 (P) or w
(R) Quantification of the number of PH3+ cells per posterior midgut expressing kis
in EBs only (NREts), in ECs only (Myo1Ats) for 10 days, or in EE cells (prosts) for 1
A Fisher’s exact test was used in (C). A two-tailedMann-Whitney test was used in
SEM; ns = non-significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Sca
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Kismet protein (Figures 2L–2N and S2A–S2E0). ISC-specific or
ISC and EB simultaneous knockdown of kismet led to an accu-
mulation of ISCs and increased proliferation (Figures 2O–2R,
S2F, and S2G). However, kismet knockdown in EEs, ECs, or in
EB cells only did not show ISC phenotypes (Figures 2R and
S2H–S2M). We conclude that kismet activity is required in ISCs
to limit their proliferation to a basal level and to prevent abnormal
expansion of their pool.Kismet Mutant Cells Activate Notch Signaling and Can
Differentiate upon Forced Notch Activation
We next explored a potential impact of kismet on the Notch
signaling pathway, which limits stem cell numbers by controlling
daughter-cell-fate decisions (Bardin et al., 2010; Micchelli and
Perrimon, 2006; Ohlstein and Spradling, 2006). We reasoned
that as a regulator of transcription, Kismet might be necessary
for expression of Notch. This was not the case, and Notch-ex-
pressing cells were in fact more abundant because of the accu-
mulation of ISCs (Figures S3A and S3B). Furthermore, a reporter
for the Notch pathway (NRE-lacZ; Notch Responsive Element),
which is restricted to the EC-committed EB cells in wild-type tis-
sue, was still expressed in kismet mutant clones, though absent
from the extra Delta+ cells (Figures S3C–S3F).
We further examined whether kismet mutants might block
Notch target gene activation. To test this, we induced kismet
mutant clones and allowed 10 days of growth to accumulate ex-
tra ISCs (Figure S3G). We then induced expression of an active
form of Notch in themutant cells (NAct) by shifting to 29C to inac-
tivate a temperature-sensitive GAL80 (GAL80ts). At 18C, control
guts showed isolated Delta+ ISCs, whereas those with induced
kismet mutant clones showed clusters of Delta+ ISCs (Figures
S3H and S3I). However, expression of NAct in kismet mutant
clones that had accumulated ISCs caused differentiation of
ISCs into ECs (Figures S3J, S3K, and S3L). Therefore, we
conclude that kismet inactivation leads to the accumulation of
extra-ISCs that maintain their potential to differentiate and acti-
vate Notch, though alteration in the kinetics of Notch signaling
activation could not be excluded.Kismet Is Required to Maintain a Basal Level of
Activation of EGFR Signaling
As EGFR signaling is one of the primary signaling pathways con-
trolling ISC proliferation (Biteau and Jasper, 2011; Buchon et al.,
2010; Jiang et al., 2011), we then investigated whether kismetarrows show PH3+ cells).
UAS-GFP-E2f1-230, UAS-mRFP-CycB1-266 FUCCI system allowing cell cycle
rrowheads show Delta+ ISCs).
s (esg+), EEs (diploid esg), and ECs (polyploid cells) from (K) and (K0).
ulation in esg+ progenitor cells (ISCs and EBs) marked by GFP and EE cells
tein and reproduced kis10D26 phenotypes.
er clone (N) in wild-type and kis RNAis expressing clones.
ith kis RNAi BL34908 (Q) for 10 days at 29C using esgts- NRE-GAL80 driver.
RNAi in the ISCs and EBs (esgts driver), in ISCs only (esgts- NRE-GAL80 driver),
0 days.
(D), (J), (M), (N), and (R). A c2 test was used for (I). Mean values in red; error bars,
le bars, 20 mm.
Figure 3. Kismet Controls Proliferation by Regulating EGFR Pathway Activity
(A–D0) Wild-type (A, A0, C, and C0) and kis10D26 (B, B0, D, and D0), 9 days AHSMARCM clones. EGFR signaling, detected by dpERK (A–B0) and EGFR target CycE-
LacZ (C–D0), was increased in kis10D26 clones.
(legend continued on next page)
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mutant stem cells may have increased EGFR signaling. In wild-
type clones at 10 days AHS, a marker for activation of the
EGFR pathway, dpERK, was weak in ISCs and mostly absent
in other clonal cells (Figures 3A and 3A0). In kismetmutant clones,
dpERK was strongly induced in ISCs and other cells of the clone
(Figures 3B and 3B0). In addition, a reporter of cyclin E, acting
downstream of EGFR signaling to regulate proliferation, was
more highly induced in kismet mutant clones compared to
wild-type at 9 days AHS and as early as 3 days AHS (Figures
3C–3G). Consistent with the rapid activation of EGFR signaling
in kismet mutants, an increased proportion of ISCs with dpERK
signaling was detected as early as 3 days after kismet RNAi in-
duction in ISCs (Figures 3H–3J). Furthermore, the abnormal
self-renewal of ISCs induced by the loss of kismetwas abolished
upon blocking EGFR signaling using a dominant negative form of
EGFR (EGFRDN) or expression of capicua (cic), a downstream
repressor of EGFR target genes (Figures 3K–3R). Not only was
kismet mutant clone size reduced when EGFR signaling was
downregulated, but there was also a reduction in the percent
of ISCs per clone, returning to wild type (Figures 3O and 3R).
This suggests that ectopic activation of EGFR signaling in kismet
mutant clones drives extra cell division and promotes the accu-
mulation of stem cells.
Previous work has shown that additional stress signaling path-
ways can further stimulate ISC proliferation due to feedback on
EGFR signaling (Patel et al., 2015). In addition to EGFR signaling,
Junkinasesignaling (assayedbypuc-LacZ) andJak/Stat signaling
(assayed by 10XSTAT GFP) were also activated in ISCs of 9 days
kismetmutant clones (FiguresS4A–S4D0). Thegenetic inactivation
of Yki, Stat, Insulin, and Jun kinase also reduced ISC proportion in
kismetmutants (Figure S4E). In order to determine whether these
pathwaysmay also act early with EGFR signaling in kismetmutant
stem cells to drive ISC proliferation, we examined a 3-day time
point after clone induction. We did not detect early activation of
the Jak/Stat ligands, Upd-LacZ, or the Jun Kinase reporter puc-
LacZ in ISCsorUpd3-LacZ inECs (FiguresS4F–S4N). This argues
against early activation of Jak/Stat and Jun Kinase pathways
being initiating defects in kismetmutant responsible for ISC prolif-
eration. Therefore, our data suggest that an initial enhancement of
EGFR signaling occurs, followed by activation of additional path-
ways during the following 10 days of clone growth and further
driving mutant clone growth. We conclude that Kismet is required
to limit EGFR signaling in ISCs.
Kismet Localizes to Chromatin Enriched in RNA Pol II
and Brahma and Depleted for HP1, Histone H1, and
Polycomb
To further understand how Kismet regulates ISC self-renewal,
we identified Kismet-bound regions of the ISC genome using a(E–F0 ) Wild-type (E and E0), and kis10D26 (F and F0 ), 3 days AHS MARCM clones e
(G) Proportion of ISCs expressing CycE-lacZ from (E) and (F0).
(H and I) ISC-specific expression of GFP (H) or kis RNAi (BL34908) (I), 3 days at
(J) Quantification of proportion of ISCs showing strong, weak, or no dpERK from
(K–N) 12-day AHS clones: wild-type (K), kis10D26 mutant (L), expressing UAS-EG
(O) Clone size, number of Delta+ cells/clone, and % of Delta+ cells/clone from (K
(P and Q) 10-day AHS clones: wild-type expressing cic (P) and kis10D26 mutant e
(R) Clone size, number of Delta+ cells/clone, and % of Delta+ cells/clone from (P
Results compared using a chi-square test in (G) and (J) and a two-tailed Mann-W
nificant, **p < 0.01, ****p > 0.0001. Arrows highlight ISCs. Scale bars, 20 mm.
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2016). A Dam-Kismet (Dam-Kis) fusion protein construct was ex-
pressed in ISCs using esgts, NRE-GAL80 for 1 day and signifi-
cantly methylated GATC sites as compared to Dam-alone con-
trol expression were determined. Kismet distribution revealed
enrichment in introns and 50 UTRs (Figure 4A). We identified
3,032 genes containing Kismet peaks, defined by two consecu-
tive significant GATC sites (p < 0.01) (Table S1).
To gain further insight into the type of chromatin bound by
Kismet, we took advantage of DamID lines mapping different
active and inactive chromatin states. Active regions are rich in
RNA Pol II and Brahma, whereas inactive states are enriched
in Polycomb (a reader of Histone H3K27me3), Histone H1, or
HP1 (a reader of histone H3K9me3) (Marshall and Brand,
2017). Global patterns of Histone H1, HP1, and Polycomb bind-
ing were consistent with localization to repressed regions of the
genome, whereas Brahma and RNA Pol II along with Kismet
were enriched in active genic regions (Figures 4B and 4L). His-
tone H1 and HP1 were largely excluded from genic regions
with HP1 strongly enriched at centromere-proximal regions of
the genome and the 4th chromosome, which is largely hetero-
chromatic in flies (Figures S5H and 4B). These data are fully
consistent with data from the nervous system (Marshall and
Brand, 2017). We then examined global distribution of Kismet
relative to RNA Pol II, Brahma, Polycomb, Histone H1, and
HP1 using uniform manifold approximation and projection for
dimension reduction (UMAP; Figure 4C [McInnes et al., 2018]).
This approach allows the visualization and separation in a two-
dimensional space, similar to a t-SNE (t-distributed stochastic
neighbor embedding) plot, of GATC sites based on methylation
levels by each of these factors (Figure 4C, GATC density map).
Globally, Kismet had little overlap on UMAP with Histone H1
and HP1 (Figure 4C) or with genes containing peaks of Histone
H1 and HP1 (2.5% and 11.3%, respectively; Figure 4D; Table
S2). A majority of Kismet-rich GATC sites did not have strong
Polycomb enrichment (Figure 4C; Table S2) and 14.5% of genes
with Kismet peaks also had peaks of Polycomb (Figure 4E).
Consistent with this, super-resolution imaging in polyploid EC
cells, which allow better spatial resolution than ISCs, showed
that Kismet and Histone H3K27me3 poorly colocalized (Figures
S5A–S5A00). Therefore, we conclude that Kismet does not sub-
stantially localize to repressed chromatin domains.
Our data suggested, however, that Kismetmore strongly over-
lapped with activated chromatin states, visualized on UMAP by
Kismet enrichment with RNA Pol II and also to some extent
with Brahma, a SWI/SNF chromatin remodeling factor associ-
ated with histone H3K27ac (Figure 4C). 85.1% of genes with
peaks for Kismet also had peaks for RNA Pol II and 33.0% had
a peak for Brahma (Figures 4F and 4G; Table S2). Together,xpressing CycE-LacZ.
29C.
(H)–(I0).
FRDN (M), and kis10D26 mutant expressing UAS-EGFRDN (N).
)–(N).
xpressing cic (Q).
) and (Q).
hitney test in (O) and (R). Mean values in red; error bars, SEM; ns = non-sig-
Figure 4. Genome-wide Mapping of Kismet Relative to RNA Pol II, Brm, Pc, HP1, and H1
(A) Kismet DamID-seq showed an enrichment of methylated GATCs in the introns and 50UTRs of genes. Unassembled regions of the genome were not
considered.
(legend continued on next page)
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these data suggest that Kismet localizes to transcriptionally
active regions of the genome while being depleted in repressed
chromatin.
Kismet Localizes to Transcriptionally Active Genomic
Regions and Developmental Enhancers
We then assessed how Kismet localized relative to active
genes and enhancers. We established a list of expressed or
‘‘active’’ ISC genes based on Dam-RNA Pol II gene occupancy,
a good proxy for gene expression (Marshall and Brand, 2015;
Southall et al., 2013) (STAR Methods). 4,539 genes had signif-
icant occupancy suggesting that they are expressed, including
many known ISC-enriched genes (esg, sox21a, Delta, and
spdo; Table S3). Accordingly, these genes strongly overlap
with published RNA sequencing (RNA-seq) data for ISC ex-
press genes (Dutta et al., 2015) (Figure 4H). We found that
67.0% of the genes with Kismet peaks were also occupied
by RNA Pol II (Figure 4I). Genes enriched for Kismet and RNA
Pol II or enriched for one but not the other were also detected
(examples in Figures S5B–S5H). Separately analyzing ISC
genes that were active (Dam-RNA Pol II occupied) or silent
(Dam-RNA Pol II not occupied) revealed that Kismet, like its
mammalian homologs CHD7/CHD8, was preferentially en-
riched around the transcription start sites (TSSs) of active
genes (Figure 4J) (Schnetz et al., 2009, 2010).
Interestingly, while Kismet showed a strong enrichment for
active genes (Figure 4J), it was also associated with a subset
of silent genes in ISCs that are expressed in differentiated EE
(Pros) and EC cells (Pdm1): 163 of 569 EE+ EC specifically en-
riched genes had Kismet peaks (from published RNA-seq (Dutta
et al., 2015; see STAR Methods; examples in Figures S5C and
S5D). Thus, while we detected no obvious roles in terminal differ-
entiation, Kismet appeared to mark a subset of genes in ISCs
that will be expressed during differentiation.
We then investigated the binding profiles of Kismet and RNA
Pol II at previously published enhancers defined in S2 cells as
being either ‘‘developmental’’ or ‘‘housekeeping’’ (Zabidi et al.,
2015). Interestingly, Kismet showed enrichment over develop-
mental enhancers, whereas RNA Pol II was enriched over both
types of enhancers (Figure 4K). Thus, we conclude that Kismet
is broadly distributed on many active genes in ISCs and is en-
riched at developmental enhancers.
Knockdown of the Components of the Trr COMPASS-
like Complex Mimic kismet Mutant Phenotypes
Kismet has previously been shown to restrict HistoneH3K27me3
marks in the salivary gland (Dorighi and Tamkun, 2013; Sriniva-(B) Genome-wide overview of the DamID binding peak density in ISCs of Kismet
(C) UMAP clustering of GATC sites based on 7 DamID fusion proteins (see STAR
clustering followed by the plots representing the binding of each protein over GA
(D–I) Venn diagrams of genes with peaks of the DamID-seq data in ISCs: Kismet
Geneswith a significantmean RNAPol II occupancy determined byDamID versus
versus genes with peaks of Kismet (I).
(J) Mean position and metaplot of Kismet, RNA Pol II, and Pc in ISCs relative to
Kismet was significantly enriched over the TSS of active genes.
(K) Mean position and metaplot of Kismet and RNA Pol II in ISC relative to previo
Zabidi et al., 2015. Kismet was found enriched over developmental enhancers.
(L) Wild-type RNA-seq, Dam-Kis, Dam-RNA Pol II, Dam-Pc, Dam-Brm, Dam-HP
region surrounding the ISC-specific gene Delta.
564 Developmental Cell 49, 556–573, May 20, 2019san et al., 2008, 2005). Therefore, we examined whether kismet
inactivation in the gut had a similar effect on limiting Histone
H3K27me3 but found no detectable global increase in
H3K27me3 in kismet mutants (Figures S6A and S6B0). Previous
studies have shown that Kismet acts in the salivary gland cells
via recruitment of the histone methyltransferases Ash1 and Trx
(Dorighi and Tamkun, 2013). Arguing against this possibility, we
found that neither ash1 nor trx clonal loss led to deregulation of
ISC proliferation (Figures S6C–S6E, S6H, and S6I). Similarly,
Brahma has been shown to co-localize with Kismet and share
similar functions in transcription elongation (Armstrong et al.,
2002; Srinivasan et al., 2005). However, consistent with previously
published data in the intestine, brahma-RNAi-expressing clones
were smaller and had fewer ISCs per clone than controls (Figures
S6F, S6H, and S6I) (Jin et al., 2013). Therefore, our data suggest
that Kismet mediates its action on ISC proliferation through direct
or indirect interaction with additional chromatin regulators.
We reasoned that additional Trithorax group genes might
function with Kismet and sought to identify these factors. To
this end, we tested the effect of the histone methyl transfer-
ases-encoding genes (Mohan et al., 2011): dSet1 (Set1A/
Set1B in mammals), and Trr (MLL3/4 in mammals). The clonal
expression of a previously validated RNAi construct against
set1 (Herz et al., 2012) had no obvious effects on ISCs or clone
size (Figure S6G). However, knockdown of genes encoding
Trr-complex proteins (Trr, Lost polyhomeotic domains of Trr
[Lpt], and the histone demethylase Utx) revealed phenotypes
similar to kismet (Figures 5A–5F). They had an increased num-
ber of cells per clone and Delta+ cells per clone (Figures 5A,
5B, 5E, and 5F). Clones of the trrB mutant allele showed less
severe but significant accumulation of extra-Delta+ diploid
ISCs (Figures S6J–S6L0). Furthermore, the knockdown of lpt
and Utx also exhibited kismet-mutant-like phenotypes (Figures
5C–5F). Analysis of Trr, Lpt, and Utx showed ubiquitous
expression in the cell types of the midgut (Figures 5G–5J0).
Utx, however, was enriched in the ISC and EB (esg+) progen-
itor cells and EEs similar to Kismet localization (Figures 5G–
5H), and Lpt was enriched in EEs (Figures 5I and 5I0). The
phenotypic similarity between kismet alleles and knockdown
of trr-complex genes suggests they may collaborate to regu-
late ISC function. This idea is further supported by our findings
that Kismet is enriched at developmental enhancers and that
the Trr/MLL3/4 complexes have well-described functions in
activating enhancers (Dorighi et al., 2017; Herz et al., 2012;
Hu et al., 2013; Lee et al., 2013). Thus, we hypothesize that
Kismet regulates ISC proliferation in conjunction with the Trr
complex., RNA Pol II, Polycomb (Pc), Brahma (Brm), HP1, and H1.
Methods) in the ISC. Density of GATC sites throughout the genome used for
TC sites.
versus HP1 or H1 (D) versus Pc (E) versus RNA Pol II (F) and versus Brm (G).
transcriptionally active genes based onRNA-seq fromDutta et al., 2015 (H) and
the TSS for genes classified by their activity based on RNA Pol II occupancy.
usly defined ‘‘developmental’’ or ‘‘housekeeping’’ enhancers in S2 cells from
1, and Dam-H1 ISC binding profiles and peaks alignments over the genomic
Figure 5. Loss of Trr COMPASS-like Complex Activity Induces Abnormal ISC Accumulation
(A–D) Wild-type (A), trr RNAi (B), lpt RNAi (C), or Utx RNAi (D) at 9 days AHS clones.
(E and F) Average number of cells (E) and ISCs (F) per clone from (A)–(D).
(G and G0) Utx was ubiquitously expressed but enriched in esg>GFP+ cells and in EE (esg>GFP diploid cells).
(H) Mean Utx staining fluorescence intensity normalized by the mean DAPI staining in ISCs, EEs, and ECs (polyploid cells) from (G) and (G0).
(I and I0) Lpt was ubiquitously expressed but enriched in EE cells (diploid; esg>GFP).
(J and J0) Trr was uniformly expressed in all midgut cell types.
In (E), (F), and (H), a two-tailed Mann-Whitney statistical test was used. Mean values in red; error bars, SEM; n = non-significant, *p < 0.05, ***p < 0.001, ****p <
0.0001. Scale bars, 20 mm.Genome-wide Co-occupancy of Kismet and Trr and Co-
regulation of Genes
A prediction of collaboration between Kismet and Trr complex is
that they may co-bind and co-regulate genes. We found that the
distribution of Kismet on polytene chromosomes largely overlap-
ped with Trr (Figures 6A–6B00) and in ISCs using targeted DamID-
seq of Trr (Figure 6C). Like Kismet, Trr was enriched over the TSS
of active genes as compared to inactive genes (based on RNA
Pol II occupancy; Figure 6D). Interestingly, while Kismet had
preferential enrichment for developmental enhancers (Figure 4K),
Trr was equally enriched at both developmental and house-
keeping enhancers (Figure 6E). Examining peaks in genes,
73.2% of Kismet-bound genes were co-bound by Trr (Figure 6F;
Table S4). We conclude that Kismet and Trr share genome-widelocalization and binding to the genes, supporting our hypothesis
that they act in concert.
We then wanted to assess whether similar genes might be de-
regulated upon kismet or trr knockdown. To this end, we used
fluorescence-activated cell sorting (FACS) to sort adult ISCs
(esgts>GFP; NRE-GAL80) of controls (white RNAi) or those ex-
pressing RNAi against kismet or trr and performed RNA-seq (Fig-
ures 6G–6I; Table S5). Interestingly, 50.3% of genes having
altered RNA upon kismet knockdown and 43.8% of genes hav-
ing altered RNA levels upon trr knockdown showed Kismet
and Trr binding by DamID-seq, respectively (Figure 6J). This sug-
gests that these genes are directly regulated by Kismet and Trr.
However, the deregulated genes represented only 10.3% and
24.3% of the total Kismet and Trr-bound genes, respectively.Developmental Cell 49, 556–573, May 20, 2019 565
Figure 6. Genome-wide Mapping of Trr DNA Binding Sites and Genes Regulated by Kismet and Trr
(A) Kismet and Trr localization on polytene chromosomes of the salivary gland.
(B–B00) Magnification of the chromosome highlighted in (A). Fluorescent intensity in (B00).
(legend continued on next page)
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Therefore, the genetic perturbation of relatively general chro-
matin binding factors can affect a limited subset of genes. This
likely underlies the specific phenotypes of general chromatin
factors noted both here in ISCs and in other contexts, such as
during human development (Bajpai et al., 2010; Schulz et al.,
2014b; Vissers et al., 2004).
Importantly, we found that 55.5% of the RNAs altered upon
knockdown of kismet were also altered in trr knockdown (Fig-
ure 6I). This represented 19.2% of the trr-altered transcripts.
Among these genes deregulated upon both kismet and trr
knockdowns, 80.2% are in the same direction, with a decrease
in transcript level (Figure 6I).
Overall, these data strongly support our hypothesis that
Kismet and Trr co-bind throughout the genome and co-regulate
gene expression.
Kismet and Trr Promote Expression of the E3 Ligase Cbl
to Maintain Low Levels of the EGF Receptor
Our previous data indicated that kismet mutant ISCs have
increased EGFR signaling (Figures 3A–3G). Similarly, upon trr
knockdown, we found deregulation of dpERK (Figures S7A–
S7B0). The similarities in loss-of-function phenotypes of kismet
and trr, the colocalization in the genome, the co-regulation of
many genes, and deregulation of EGFR signaling led us to pro-
pose that Kismet and the Trr complex act together to limit ISC
self-renewal through EGFR regulation.
Assessing our DamID-seq and RNA-seq data for regulators of
EGFR signaling, we identified Cbl, encoding an E3 ligase known
to promote degradation of EGFR (Duan et al., 2003; Hime et al.,
1997; Levkowitz et al., 1999; Meisner et al., 1997; Pai et al., 2000;
Soubeyran et al., 2002). Cbl was bound by both Kismet and Trr
and, long and short isoforms of Cbl were downregulated upon
inactivation of kismet and trr (Figures 6H, 6K, and 6L). Of note,
none of the core components of the Hippo pathway are deregu-
lated upon kismet knockdown, arguing against this pathway be-
ing involved in initiation of kismet mutant phenotypes. If Kismet
and Trr control the levels of EGFR via Cbl, then kismet and trr
knockdown contexts would lead to increased EGFR protein.
Clones expressing RNAi against Cbl, kismet, or mutant for
kismet, had a strong increase in EGFR levels, both in clones at
10 days AHS and upon 3-day induction in ISCs (Figures 6M–
6O0, S6O–S6R0, and S6T). Knockdown of trr also showed
increased EGFR levels in 10 days clones (Figures 6P and 6P0),
although upon 3-day knockdown in ISC, this was less pro-
nounced than that of kismet knockdown (Figures S6Q, S6S,
and S6T), consistent with Cbl transcripts being less reduced(C) Trr binding in the ISC clustered using UMAP based on 7 DamID fusion protei
(D) Mean position andmetaplot of Trr in ISCs plotted relative to the TSS for genes
over the TSS of active genes.
(E) Mean position and metaplot of Trr in ISC over previously defined ‘‘developme
(F) Overlap between genes with peaks of Kismet versus Trr.
(G) Principal-component analysis of RNA-seq.
(H) Differentially expressed genes; red points highlight common genes.
(I) Upper: overlap between genes with RNAs deregulated upon kis and trr knockd
(J) Upper: genes with peaks of Kismet and deregulated after kis knockdown in the
(K) RNA-seq data showing downregulation of the 2 Cbl isoforms upon either kis
(L) Alignement at the Cbl locus of wild-type RNA-seq, Kismet, Trr, RNA Pol II, Pc,
(M–P0) clone of wild-type (M and M0), Cbl RNAi (N and N0), kis10D26 (O and O0 ) an
bars, 20 mm.upon trr knockdown than upon kismet knockdown (Figure 6K).
Furthermore, the expression of Cbl-L isoform (but not Cbl-S) in
kismet RNAi-expressing clones rescued clone size and accumu-
lation of Delta+ cells supporting that Cbl acts downstream of
Kismet to regulate ISC self-renewal (Figures 7A–7H). In agree-
ment with previous work (Jiang et al., 2011), the knockdown of
Cbl led to larger clones with increased numbers of Dl+ ISCs
and excessive proliferation (Figures 7I–7O). In addition, trr
mutant phenotypes could be suppressed by conditions that low-
ered EGFR signaling (expression of EGFR-DN or cic; Figures
7P–7W).
Finally, if kismet and trr act on similar target genes, we would
predict that their combined phenotype would be like kismetmu-
tants, which is indeed what was found (Figures S7C–S7G).
Together, our data suggest that one of the downstream targets
of Kismet and Trr required to maintain a basal level of ISC prolif-
eration is the E3 ligase encoding gene Cbl, which modulates
EGFR protein levels and signaling activation.
DISCUSSION
Through an unbiased genetic screen, we have identified the
chromatin remodeling factor Kismet/CHD7/CHD8, as a regulator
of stem cell proliferation in the fly intestine. By establishing the
first genome-wide binding map of Kismet in Drosophila, our
data revealed a large overlap with transcriptionally active re-
gions. Interestingly, our genome-wide mapping and RNA-seq
data suggest that Kismet mediates its role on ISCs through
collaboration with the Trr complex and that the negative regu-
lator of EGFR, Cbl, is one critical downstream direct target of
kismet and trr, leading to the deregulation of EGFR signaling.
Altogether, our data uncover an important level of chromatin
regulation required to dampen the ISC proliferative response in
routine homeostasis.
In response to homeostatic cell turnover and induced damage,
many signaling pathways regulate ISC proliferation rates, though
how chromatin regulation impinges on this was not understood.
Our data show that Kismet and Trr play essential roles in prevent-
ing excess ISC proliferation through limiting EGFR signaling,
which may be required after stress for the return to basal levels
of proliferation. In addition to EGFR signaling, we find that inhibi-
tion of additional pathways can suppress kismet phenotypes,
reminiscent to ‘‘niche appropriation’’ described forNotchmutant
tissue: after initial deregulation of stem cell proliferation and local
tissue perturbation due to Notch inactivation, multiple signaling
pathways become activated, including Jnk and Jak/Statns (STAR Methods and Figure 4C).
according to their activity based on RNA Pol II occupancy shows its enrichment
ntal’’ or ‘‘housekeeping’’ enhancers in S2 cells from Zabidi et al., 2015.
own in the ISCs. Lower: proportion of RNAs altered in kis and trr knockdown.
ISCs. Lower: genes with peaks of Trr and deregulated after trr KD in the ISCs.
RNAi and trr RNAi in the ISC.
Brm, HP1, H1 binding profiles and peaks as determined by DamID-seq in ISCs.
d trr RNAi (P and P0), 10 days AHS. Arrows show EGFR-positive cells. Scale
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Figure 7. Trr and Kismet Regulates EGFR Activity through the Control of Cbl Expression
(A–F) Clone of wild-type (A), kis RNAi34908 (B), UAS-Cbl-L (C), both kis RNAi34908 and UAS-Cbl-L (D), UAS-Cbl-S (E), and both kis RNAi34908 and UAS-Cbl-S (F) at
9 days AHS.
(legend continued on next page)
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signaling, which function together to further drive ISC prolifera-
tion (Patel et al., 2015). Thus, our findings suggest that niche
appropriation is a general property of rapidly proliferating tissues
that create stress signals in the gut, further fueling cell division.
Interestingly, our findings suggested that Kismet is enriched at
genes that are expressed not only in ISCs but also at a subset of
genes that is OFF in the stem cell but will be later turned ON dur-
ing the differentiation process. Of note, we did not detect
obvious defects in terminal cell fate differentiation in kismet
mutant clones using well-characterized markers of EE and EC
cells. Further analysis of kismet mutant EE and EC cells will
determine whether there are more subtle defects in differentia-
tion or not. This raises the possibility that Kismet may be a
good marker of pre-patterning of lineage-specific genes.
Our data suggest that Kismet cooperates with the Trr complex
to regulate many genes. CHARGE syndrome, due to a heterozy-
gous mutation of CHD7 in humans, has extensive phenotypic
overlap with Kabuki syndrome, caused by mutation of MLL4
(also known as KMT2D and MLL2) and UTX (also known as
KDM6A) (Butcher et al., 2017; Miyake et al., 2013; Ng et al.,
2010; Schulz et al., 2014a). These data raise the question of a
similar collaboration between these enzymes in human develop-
ment. The Trr/MLL3/4 complexes establish the H3K4me1 mark,
enriched at primed and active enhancers and, to some extent,
promoters. Could Kismet/CHD7 remodeling activity promote
H3K4me1? Our data argue against this since H3K4me1 was
reduced in the gut upon knockdown of trr and lpt (Figures
S7L–S7N0), but not altered in kismet mutant clones (Figures
S7O and S7O0). In addition, no obvious defects were detected
in histone H3K27ac in kismet mutant clones (Figures S6M–
S6N0) or protein levels of Trr in kismet mutants or of Kismet
in trrmutants were found (Figures S7H–S7K0). It is possible, how-
ever, that Kismet/CHD7 might promote the methyltransferase-
independent activity of Trr/MLL3/4 that has been shown to regu-
late enhancer efficiency (Dorighi et al., 2017; Rickels et al., 2017).
Further evidence suggesting a molecular link between Kismet/
CHD7/CHD8 and the Trr/MLL3/4 complex comes from co-
immunoprecipitation (coIP) between Kismet and CBP, a binding
partner of the Trr complex component Utx and between CHD7/
CHD8 and the MLL3/4 complex components WDR, ASH2L, and
RbBP5 (Schulz et al., 2014a; Thompson et al., 2008; Tie et al.,
2012). Thus, we speculate that Kismet and the Trr complex
may both be necessary for regulation of a subset of genes,
such as Cbl.
In addition to similar phenotypes of CHD7 and MLL4 muta-
tions on human development, both CHD7 and MLL3/4 complex
components are mutated in cancers. CHD7 is found as a highly
expressed fusion protein in small cell lung cancers (Pleasance
et al., 2010). A subset of colorectal carcinomas and gastric can-(G and H) Average number of cells and ISC per clone from (A)–(F).
(I and J) Clones of wild-type (I) and Cbl RNAi (J) 10 days AHS.
(K and L) Average number of cells and ISC per clone from (I) and (J).
(M and N) ISC-specific expression of GFP (M) and Cbl RNAi (N) driven by esgts- N
GFP, Delta+ cells.
(O) Quantification of number of PH3+ cells per gut from (M) and (N).
(P–U) Clone of wild-type (P), trr RNAi (Q), UAS-EGFRDN (R), both trr RNAi and UA
(V andW) Clone size (V) and number of Delta+ per clone (W) from (P)–(U). Results w
red; error bars, SEM; n = non-significant, *p < 0.05, **p < 0.01, ****p < 0.0001. Scers were found to have frequent mutations in both CHD7 and
its closely related gene, CHD8 (Kim et al., 2011; Sawada et al.,
2013; Tahara et al., 2014). Mutations in CHD7 and in the
MLL3/4 complex are frequently found in medulloblastoma, and
MLL3/4 is also found inactivated in many additional cancers
(Ford and Dingwall, 2015; Robinson et al., 2012). How deregulat-
ing CHD7 and MLL3/4 may impact cancer progression is not
entirely clear, though recent studies linking enhancer and
super-enhancer deregulation to cancer formation suggest that
the deregulation of enhancers upon mutation of Kismet/CHD7
and the Trr/MLL3/4 complex could drive aberrant proliferation
(Herz et al., 2014; Hnisz et al., 2013). While much of what we
know about chromatin regulation in stem cells comes from
studies of cultured embryonic stem cells, our work provides
insight into in vivo roles of chromatin remodeling factors in con-
trol of adult stem cell self-renewal and proliferation programs.
Our findings that Kismet and the Trr complex loss lead to dra-
matic alteration of ISC proliferation indicate that the Drosophila
intestine will be a useful model to probe the relationship between
chromatin regulation and stem cell proliferation control.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILSB Generation of Transgenic Flies
B Clonal Analysis and Gal4 Expression
B Immunofluorescence and Imaging
B DamID-Seq Analysis
B RNAseq Analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
d DATA AND SOFTWARE AVAILABILITY
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
devcel.2019.04.033.
ACKNOWLEDGMENTS
Wewould like to thank themembers of the Bardin team and P.-A. Defossez for
comments on the manuscript. We thank O. Ayrault and A. Forget for help with
biochemical experiments; C. Carre´ for help with polytene experiments; and S.
Maffioletti, A. Osnato, and T. Gonc¸alves for their technical help on some exper-
iments. We thank A. Shilatifard, B.A. Edgar, D.R. Marenda, S. Bray,M. Haenlin,
J. Skeath, J. Veenstra, and the Bloomington and Vienna stock centers forRE-GAL80 for 10 days at 29C. Cbl knockdown results in an accumulation of
S-EGFRDN (S), UAS-cic (T), and both trr RNAi and UAS-cic (U) at 10 days AHS.
ere compared using a two-tailedMann-Whitney statistical test. Mean values in
cale bars, 20 mm.
Developmental Cell 49, 556–573, May 20, 2019 569
antibodies and fly lines. The Bardin laboratory is supported by project grants to
A.B.: 2017 prize from Fondation Schlumberger, Worldwide Cancer Research,
ATIP-AVENIR, La Ligue Contre le Cancer, and Fondation ARC, the Charge
Syndrome Foundation, and labelisation of the Fondation pour la Recherche
Medicale as well as funding from the program ‘‘Investissements d’Avenir’’
launched by the French Government and implemented by ANR; references:
ANR SoMuSeq-STEM (A.B.), Labex DEEP (ANR-11-LBX-0044) and IDEX
PSL (ANR-10-IDEX-0001-02 P.S.L.). We would like to acknowledge the Cell
and Tissue Imaging Facility/UMR3215 (PICT-IBiSA) of the Institut Curie, mem-
ber of the French National Research Infrastructure France-BioImaging, ANR-
10- INBS-04, and T. Piolot for help on the OMX microscope. We thank the
NGS platform of the Institut Curie, which is supported by grants ANR-10-
EQPX-03 and ANR10-INBS-09-08 and Canceropoˆle IdF. F.S. is supported
by Labex REVIVE (ANR-10-LABX-0073). Work in the Brand lab was funded
by the Royal Society Darwin Trust Research Professorship, Wellcome Trust
Senior Investigator award 103792, Biological Sciences Research Council proj-
ect grant BB/L00786X/1 (to A.H.B.), and European Molecular Biology Organi-
zation long-term fellowship ALTF 423-2011 (to O.J.M.). A.H.B. acknowledges
core funding to the Gurdon Institute from the Wellcome Trust (092096) and the
Royal Society, United Kingdom (C6946/A14492).AUTHOR CONTRIBUTIONS
L.G. performed amajority of the experiments. M.v.d.B. developed peak calling
methodology, analyzed RNA-seq data, and performedUMAPplots. M.J., L.G.,
and J.S. performed DamID-seq and helped with bioinformatic analysis. O.J.M.
and A.H.B. contributed to targeted DamID-seq experiments. C.N.P., A.J.B.,
and F.S. designed the genetic screen, which was performed by C.N.P. and
A.J.B. M.S., P.S., and K.M. built plasmids. The ‘‘polii.gene.call’’ script was de-
signed by O.J.M. and used by L.G. L.G. and A.J.B. conceived and supervised
the study, analyzed the data, andwrote themanuscript with contributions from
the other authors.DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: January 10, 2018
Revised: March 15, 2019
Accepted: April 18, 2019
Published: May 20, 2019REFERENCES
Adachi-Yamada, T., Nakamura, M., Irie, K., Tomoyasu, Y., Sano, Y., Mori, E.,
Goto, S., Ueno, N., Nishida, Y., and Matsumoto, K. (1999). p38 mitogen-acti-
vated protein kinase can be involved in transforming growth factor beta super-
family signal transduction in Drosophila wing morphogenesis. Mol. Cell. Biol.
19, 2322–2329.
Afgan, E., Baker, D., van den Beek, M., Blankenberg, D., Bouvier, D., Cech, M.,
Chilton, J., Clements, D., Coraor, N., Eberhard, C., et al. (2016). The Galaxy
platform for accessible, reproducible and collaborative biomedical analyses:
2016 update. Nucleic Acids Res. 44, W3–W10.
Armstrong, J.A., Papoulas, O., Daubresse, G., Sperling, A.S., Lis, J.T., Scott,
M.P., and Tamkun, J.W. (2002). The Drosophila BRM complex facilitates
global transcription by RNA polymerase II. EMBO J. 21, 5245–5254.
Bajpai, R., Chen, D.A., Rada-Iglesias, A., Zhang, J., Xiong, Y., Helms, J.,
Chang, C.P., Zhao, Y., Swigut, T., and Wysocka, J. (2010). CHD7 cooperates
with PBAF to control multipotent neural crest formation. Nature 463, 958–962.
Balakireva, M., Stocker, R.F., Gendre, N., and Ferveur, J.F. (1998). Voila, a
new Drosophila courtship variant that affects the nervous system: behavioral,
neural, and genetic characterization. J. Neurosci. 18, 4335–4343.
Bardin, A.J., Perdigoto, C.N., Southall, T.D., Brand, A.H., and Schweisguth, F.
(2010). Transcriptional control of stem cell maintenance in the Drosophila
intestine. Development 137, 705–714.570 Developmental Cell 49, 556–573, May 20, 2019Biteau, B., Hochmuth, C.E., and Jasper, H. (2008). JNK activity in somatic
stem cells causes loss of tissue homeostasis in the aging Drosophila Gut.
Cell Stem Cell 3, 442–455.
Biteau, B., and Jasper, H. (2011). EGF signaling regulates the proliferation of
intestinal stem cells in Drosophila. Development 138, 1045–1055.
Bouazoune, K., and Kingston, R.E. (2012). Chromatin remodeling by the CHD7
protein is impaired by mutations that cause human developmental disorders.
Proc. Natl. Acad. Sci. USA 109, 19238–19243.
Brennan, K., Tateson, R., Lieber, T., Couso, J.P., Zecchini, V., and Arias, A.M.
(1999). The abruptexmutations of notch disrupt the establishment of proneural
clusters in Drosophila. Dev. Biol. 216, 230–242.
Brunet, A., and Rando, T.A. (2017). Interaction between epigenetic and meta-
bolism in aging stem cells. Curr. Opin. Cell Biol. 45, 1–7.
Buchon, N., Broderick, N.A., Kuraishi, T., and Lemaitre, B. (2010). Drosophila
EGFR pathway coordinates stem cell proliferation and gut remodeling
following infection. BMC Biol. 8, 152.
Buchon, N., Broderick, N.A., Poidevin, M., Pradervand, S., and Lemaitre, B.
(2009). Drosophila intestinal response to bacterial infection: activation of
host defense and stem cell proliferation. Cell Host Microbe 5, 200–211.
Buff, E., Carmena, A., Gisselbrecht, S., Jime´nez, F., and Michelson, A.M.
(1998). Signalling by the Drosophila epidermal growth factor receptor is
required for the specification and diversification of embryonic muscle progen-
itors. Development 125, 2075–2086.
Butcher, D.T., Cytrynbaum, C., Turinsky, A.L., Siu, M.T., Inbar-Feigenberg, M.,
Mendoza-Londono, R., Chitayat, D., Walker, S., Machado, J., Caluseriu, O.,
et al. (2017). CHARGE and Kabuki syndromes: gene-specific DNAmethylation
signatures identify epigenetic mechanisms linking these clinically overlapping
conditions. Am. J. Hum. Genet. 100, 773–788.
Challen, G.A., Sun, D., Mayle, A., Jeong, M., Luo, M., Rodriguez, B., Mallaney,
C., Celik, H., Yang, L., Xia, Z., et al. (2014). Dnmt3a and Dnmt3b have overlap-
ping and distinct functions in hematopoietic stem cells. Cell Stem Cell 15,
350–364.
Chen, J., Xu, N., Wang, C., Huang, P., Huang, H., Jin, Z., Yu, Z., Cai, T., Jiao,
R., and Xi, R. (2018). Transient Scute activation via a self-stimulatory loop di-
rects enteroendocrine cell pair specification from self-renewing intestinal
stem cells. Nat. Cell Biol. 20, 152–161.
Choksi, S.P., Southall, T.D., Bossing, T., Edoff, K., deWit, E., Fischer, B.E., van
Steensel, B., Micklem, G., and Brand, A.H. (2006). Prospero acts as a binary
switch between self-renewal and differentiation in Drosophila neural stem
cells. Dev. Cell 11, 775–789.
Cordero, J.B., Stefanatos, R.K., Scopelliti, A., Vidal, M., and Sansom, O.J.
(2012). Inducible progenitor-derived Wingless regulates adult midgut regener-
ation in Drosophila. EMBO J. 31, 3901–3917.
Daubresse, G., Deuring, R., Moore, L., Papoulas, O., Zakrajsek, I., Waldrip,
W.R., Scott, M.P., Kennison, J.A., and Tamkun, J.W. (1999). The Drosophila
kismet gene is related to chromatin-remodeling factors and is required for
both segmentation and segment identity. Development 126, 1175–1187.
de Sousa e Melo, F., Kurtova, A.V., Harnoss, J.M., Kljavin, N., Hoeck, J.D.,
Hung, J., Anderson, J.E., Storm, E.E., Modrusan, Z., Koeppen, H., et al.
(2017). A distinct role for Lgr5+ stem cells in primary andmetastatic colon can-
cer. Nature 543, 676–680.
Dietzl, G., Chen, D., Schnorrer, F., Su, K.C., Barinova, Y., Fellner, M., Gasser,
B., Kinsey, K., Oppel, S., Scheiblauer, S., et al. (2007). A genome-wide trans-
genic RNAi library for conditional gene inactivation in Drosophila. Nature 448,
151–156.
Dorighi, K.M., Swigut, T., Henriques, T., Bhanu, N.V., Scruggs, B.S., Nady, N.,
Still, C.D., II, Garcia, B.A., Adelman, K., and Wysocka, J. (2017). Mll3 and Mll4
facilitate enhancer RNA synthesis and transcription from promoters indepen-
dently of H3K4 monomethylation. Mol. Cell 66, 568–576.e4.
Dorighi, K.M., and Tamkun, J.W. (2013). The trithorax group proteins Kismet
and ASH1 promote H3K36 dimethylation to counteract Polycomb group
repression in Drosophila. Development 140, 4182–4192.
Duan, L., Miura, Y., Dimri, M., Majumder, B., Dodge, I.L., Reddi, A.L., Ghosh,
A., Fernandes, N., Zhou, P., Mullane-Robinson, K., et al. (2003). Cbl-mediated
ubiquitinylation is required for lysosomal Sorting of epidermal growth factor re-
ceptor but is dispensable for endocytosis. J. Biol. Chem. 278, 28950–28960.
Dubruille, R., Murad, A., Rosbash, M., and Emery, P. (2009). A constant light-
genetic screen identifies KISMET as a regulator of circadian photoresponses.
PLoS Genet. 5, e1000787.
Dutta, D., Dobson, A.J., Houtz, P.L., Gl€aßer, C., Revah, J., Korzelius, J., Patel,
P.H., Edgar, B.A., and Buchon, N. (2015). Regional cell-specific transcriptome
mapping reveals regulatory complexity in the adult Drosophila Midgut. Cell
Rep. 12, 346–358.
Dutta, D., Xiang, J., and Edgar, B.A. (2013). RNA expression profiling from
FACS-isolated cells of the Drosophila intestine. Curr. Protoc. Stem Cell Biol.
27. Unit 2F.2.
Ekas, L.A., Baeg, G.H., Flaherty, M.S., Ayala-Camargo, A., and Bach, E.A.
(2006). JAK/STAT signaling promotes regional specification by negatively
regulating wingless expression in Drosophila. Development 133, 4721–4729.
Feng, W., Kawauchi, D., Ko¨rkel-Qu, H., Deng, H., Serger, E., Sieber, L.,
Lieberman, J.A., Jimeno-Gonza´lez, S., Lambo, S., Hanna, B.S., et al. (2017).
Chd7 is indispensable for mammalian brain development through activation
of a neuronal differentiation programme. Nat. Commun. 8, 1–14.
Feng, W., Khan, M.A., Bellvis, P., Zhu, Z., Bernhardt, O., Herold-Mende, C.,
and Liu, H.K. (2013). The chromatin remodeler CHD7 regulates adult neuro-
genesis via activation of SoxC transcription factors. Cell Stem Cell 13, 62–72.
Flavahan, W.A., Gaskell, E., and Bernstein, B.E. (2017). Epigenetic plasticity
and the hallmarks of cancer. Science 357, eaal2380.
Ford, D.J., and Dingwall, A.K. (2015). The cancer COMPASS: navigating the
functions of MLL complexes in cancer. Cancer Genet. 208, 178–191.
Furriols, M., and Bray, S. (2001). A model Notch response element detects
Suppressor of Hairless–dependent molecular switch. Curr. Biol. 11, 60–64.
Gindhart, J.G., and Kaufman, T.C. (1995). Identification of Polycomb and tri-
thorax group responsive elements in the regulatory region of the Drosophila
homeotic gene Sex combs reduced. Genetics 139, 797–814.
Gramates, L.S., Marygold, S.J., Santos, G.D., Urbano, J.M., Antonazzo, G.,
Matthews, B.B., Rey, A.J., Tabone, C.J., Crosby, M.A., Emmert, D.B., et al.
(2017). FlyBase at 25: looking to the future. Nucleic Acids Res. 45, D663–D671.
Guo, Z., Driver, I., and Ohlstein, B. (2013). Injury-induced BMP signaling nega-
tively regulates Drosophila midgut homeostasis. J. Cell Biol. 201, 945–961.
Haelterman, N.A., Jiang, L., Li, Y., Bayat, V., Sandoval, H., Ugur, B., Tan, K.L.,
Zhang, K., Bei, D., Xiong, B., et al. (2014). Large-scale identification of chem-
ically induced mutations in Drosophila melanogaster. Genome Res. 24,
1707–1718.
Herz, H.M., Hu, D., and Shilatifard, A. (2014). Enhancer malfunction in cancer.
Mol. Cell 53, 859–866.
Herz, H.M., Mohan, M., Garruss, A.S., Liang, K., Takahashi, Y.H., Mickey, K.,
Voets, O., Verrijzer, C.P., and Shilatifard, A. (2012). Enhancer-associatedH3K4
monomethylation by trithorax-related, the Drosophila homolog of mammalian
Mll3/Mll4. Genes Dev. 26, 2604–2620.
Hime, G.R., Dhungat, M.P., Ng, A., and Bowtell, D.D. (1997). D-Cbl, the
Drosophila homologue of the c-Cbl proto-oncogene, interacts with the
Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding
sites. Oncogene 14, 2709–2719.
Hnisz, D., Abraham, B.J., Lee, T.I., Lau, A., Saint-Andre´, V., Sigova, A.A., Hoke,
H.A., and Young, R.A. (2013). Super-enhancers in the control of cell identity
and disease. Cell 155, 934–947.
Hochmuth, C.E., Biteau, B., Bohmann, D., and Jasper, H. (2011). Redox regu-
lation by keap1 and nrf2 controls intestinal stem cell proliferation in Drosophila.
Cell Stem Cell 8, 188–199.
Hu, D., Gao, X., Morgan, M.A., Herz, H.M., Smith, E.R., and Shilatifard, A.
(2013). The MLL3/MLL4 branches of the COMPASS family function as major
histone H3K4 monomethylases at enhancers. Mol. Cell. Biol. 33, 4745–4754.
Jiang, H., Grenley, M.O., Bravo, M.J., Blumhagen, R.Z., and Edgar, B.A.
(2011). EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeo-
stasis and regeneration in drosophila. Cell Stem Cell 8, 84–95.Jiang, H., Patel, P.H., Kohlmaier, A., Grenley, M.O., McEwen, D.G., and Edgar,
B.A. (2009). Cytokine/Jak/stat signalingmediates regeneration and homeosta-
sis in the Drosophila Midgut. Cell 137, 1343–1355.
Jiang, H., Tian, A., and Jiang, J. (2016). Intestinal stem cell response to injury:
lessons from Drosophila. Cell. Mol. Life Sci. 73, 3337–3349.
Jin, Y., Ha, N., Fore´s, M., Xiang, J., Gl€aßer, C., Maldera, J., Jime´nez, G., and
Edgar, B.A. (2015). EGFR/Ras signaling controls drosophila intestinal stem
cell proliferation via capicua-regulated genes. PLoS Genet. 11, e1005634.
Jin, Y., Xu, J., Yin, M.X., Lu, Y., Hu, L., Li, P., Zhang, P., Yuan, Z., Ho, M.S., Ji,
H., et al. (2013). Brahma is essential for Drosophila intestinal stem cell prolifer-
ation and regulated by Hippo signaling. Elife 2, e00999.
Jones, K.M., Saric, N., Russell, J.P., Andoniadou, C.L., Scambler, P.J., and
Basson, M.A. (2015). CHD7 maintains neural stem cell quiescence and pre-
vents premature stem cell depletion in the adult hippocampus. Stem Cells
33, 196–210.
Kennison, J.A., and Tamkun, J.W. (1988). Dosage-dependent modifiers of pol-
ycomb and antennapedia mutations in Drosophila. Proc. Natl. Acad. Sci. USA
85, 8136–8140.
Kim, M.S., Chung, N.G., Kang, M.R., Yoo, N.J., and Lee, S.H. (2011). Genetic
and expressional alterations of CHD genes in gastric and colorectal cancers.
Histopathology 58, 660–668.
Ko, M., Bandukwala, H.S., An, J., Lamperti, E.D., Thompson, E.C., Hastie, R.,
Tsangaratou, A., Rajewsky, K., Koralov, S.B., and Rao, A. (2011). Ten-Eleven-
Translocation 2 (TET2) negatively regulates homeostasis and differentiation of
hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 108,
14566–14571.
Langmead, B., and Salzberg, S.L. (2012). Fast gapped-read alignment with
Bowtie. Nat. Methods 9, 357–359.
Lee, J.E., Wang, C., Xu, S., Cho, Y.W., Wang, L., Feng, X., Baldridge, A.,
Sartorelli, V., Zhuang, L., Peng, W., et al. (2013). H3K4 mono- and di-methyl-
transferase MLL4 is required for enhancer activation during cell differentiation.
Elife 2, e01503.
Lee, T., and Luo, L. (1999). Mosaic analysis with a repressible cell marker for
studies of gene function in neuronal morphogenesis. Neuron 22, 451–461.
Levkowitz, G., Waterman, H., Ettenberg, S.A., Katz, M., Tsygankov, A.Y.,
Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., et al. (1999). Ubiquitin
ligase activity and tyrosine phosphorylation underlie suppression of growth
factor signaling by c-Cbl/Sli-1. Mol. Cell 4, 1029–1040.
Li, H., Qi, Y., and Jasper, H. (2013). Dpp signaling determines regional stem
cell identity in the regenerating adult drosophila gastrointestinal tract. Cell
Rep. 4, 10–18.
Li, Z., Guo, Y., Han, L., Zhang, Y., Shi, L., Huang, X., and Lin, X. (2014). Debra-
mediated CI degradation controls tissue homeostasis in drosophila adult
midgut. Stem Cell Reports 2, 135–144.
Lin, G., Xu, N., and Xi, R. (2008). Paracrine Wingless signalling controls self-
renewal of Drosophila intestinal stem cells. Nature 455, 1119–1123.
Love, M.I., Huber, W., and Anders, S. (2014). Moderated estimation of fold
change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550.
Marshall, O.J., and Brand, A.H. (2015). damidseq_pipeline: an automated
pipeline for processing DamID sequencing datasets. Bioinformatics 31,
3371–3373.
Marshall, O.J., and Brand, A.H. (2017). Chromatin state changes during neural
development revealed by in vivo cell-type specific profiling. Nat. Commun.
8, 2271.
Marshall, O.J., Southall, T.D., Cheetham, S.W., and Brand, A.H. (2016). Cell-
type-specific profiling of protein–DNAinteractions without cell isolation using
targetedDamID with next-generation sequencing. Nat. Protoc. 11, 1586–1598.
McInnes, L., Healy, J., andMelville, J. (2018). UMAP: uniformmanifold approx-
imation and projection for dimension reduction.
Meisner, H., Daga, A., Buxton, J., Ferna´ndez, B., Chawla, A., Banerjee, U., and
Czech, M.P. (1997). Interactions of Drosophila Cbl with epidermal growth fac-
tor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell.
Biol. 17, 2217–2225.Developmental Cell 49, 556–573, May 20, 2019 571
Melicharek, D., Shah, A., DiStefano, G., Gangemi, A.J., Orapallo, A., Vrailas-
Mortimer, A.D., and Marenda, D.R. (2008). Identification of novel regulators
of atonal expression in the developing Drosophila retina. Genetics 180,
2095–2110.
Melicharek, D.J., Ramirez, L.C., Singh, S., Thompson, R., and Marenda, D.R.
(2010). Kismet/CHD7 regulates axon morphology, memory and locomotion in
a Drosophila model of CHARGE syndrome. Hum. Mol. Genet. 19, 4253–4264.
Micchelli, C.A., and Perrimon, N. (2006). Evidence that stem cells reside in the
adult Drosophila midgut epithelium. Nature 439, 475–479.
Miyake, N., Koshimizu, E., Okamoto, N., Mizuno, S., Ogata, T., Nagai, T.,
Kosho, T., Ohashi, H., Kato, M., Sasaki, G., et al. (2013). MLL2 and KDM6A
mutations in patients with Kabuki syndrome. Am. J. Med. Genet. 161A,
2234–2243.
Mohan, M., Herz, H.M., Smith, E.R., Zhang, Y., Jackson, J., Washburn, M.P.,
Florens, L., Eissenberg, J.C., and Shilatifard, A. (2011). The COMPASS family
of H3K4 methylases in drosophila. Mol. Cell. Biol. 31, 4310–4318.
Neale, B.M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K.E., Sabo, A., Lin, C.F.,
Stevens, C.,Wang, L.S., Makarov, V., et al. (2012). Patterns and rates of exonic
de novo mutations in autism spectrum disorders. Nature 485, 242–245.
Ng, S.B., Bigham, A.W., Buckingham, K.J., Hannibal, M.C., McMillin, M.J.,
Gildersleeve, H.I., Beck, A.E., Tabor, H.K., Cooper, G.M., Mefford, H.C.,
et al. (2010). Exome sequencing identifies MLL2 mutations as a cause of
Kabuki syndrome. Nat. Genet. 42, 790–793.
O’Roak, B.J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B.P., Levy,
R., Ko, A., Lee, C., Smith, J.D., et al. (2012). Sporadic autism exomes reveal a
highly interconnected protein network of de novo mutations. Nature 485,
246–250.
O’Brien, L.E., Soliman, S.S., Li, X., and Bilder, D. (2011). Alteredmodes of stem
cell division drive adaptive intestinal growth. Cell 147, 603–614.
Ohlstein, B., and Spradling, A. (2006). The adult Drosophila posterior midgut is
maintained by pluripotent stem cells. Nature 439, 470–474.
Ohlstein, B., and Spradling, A. (2007). Multipotent Drosophila intestinal stem
cells specify daughter cell fates by differential notch signaling. Science 315,
988–992.
Pai, L.M., Barcelo, G., and Sch€upbach, T. (2000). D-cbl, a negative regulator of
the Egfr pathway, is required for dorsoventral patterning in Drosophila oogen-
esis. Cell 103, 51–61.
Patel, P.H., Dutta, D., and Edgar, B.A. (2015). Niche appropriation by
Drosophila intestinal stem cell tumours. Nat. Cell Biol. 17, 1182–1192.
Patro, R., Duggal, G., Love, M.I., Irizarry, R.A., and Kingsford, C. (2017).
Salmon provides fast and bias-aware quantification of transcript expression.
Nat. Methods 14, 417–419.
Perdigoto, C.N., Schweisguth, F., and Bardin, A.J. (2011). Distinct levels of
Notch activity for commitment and terminal differentiation of stem cells in
the adult fly intestine. Development 138, 4585–4595.
Perkins, L.A., Holderbaum, L., Tao, R., Hu, Y., Sopko, R., McCall, K., Yang-
Zhou, D., Flockhart, I., Binari, R., Shim, H.S., et al. (2015). The transgenic
RNAi project at Harvard Medical School: resources and validation. Genetics
201, 843–852.
Pleasance, E.D., Stephens, P.J., O’Meara, S., McBride, D.J., Meynert, A.,
Jones, D., Lin, M.L., Beare, D., Lau, K.W., Greenman, C., et al. (2010). A
small-cell lung cancer genome with complex signatures of tobacco exposure.
Nature 463, 184–190.
Quinlan, A.R., and Hall, I.M. (2010). BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics 26, 841–842.
Ramı´rez, F., D€undar, F., Diehl, S., Gr€uning, B.A., and Manke, T. (2014).
deepTools: a flexible platform for exploring deep-sequencing data. Nucleic
Acids Res. 42, W187–W191.
Ren, F., Wang, B., Yue, T., Yun, E.Y., Ip, Y.T., and Jiang, J. (2010). Hippo
signaling regulates Drosophila intestine stem cell proliferation throughmultiple
pathways. Proc. Natl. Acad. Sci. USA 107, 21064–21069.
Rickels, R., Herz, H.M., Sze, C.C., Cao, K., Morgan, M.A., Collings, C.K.,
Gause, M., Takahashi, Y.H., Wang, L., Rendleman, E.J., et al. (2017).
Histone H3K4 monomethylation catalyzed by Trr and mammalian572 Developmental Cell 49, 556–573, May 20, 2019COMPASS-like proteins at enhancers is dispensable for development and
viability. Nat. Genet. 49, 1647–1653.
Risso, D., Ngai, J., Speed, T.P., and Dudoit, S. (2014). Normalization of RNA-
seq data using factor analysis of control genes or samples. Nat. Biotechnol.
32, 896–902.
Robinson, G., Parker, M., Kranenburg, T.A., Lu, C., Chen, X., Ding, L., Phoenix,
T.N., Hedlund, E., Wei, L., Zhu, X., et al. (2012). Novel mutations target distinct
subgroups of medulloblastoma. Nature 488, 43–48.
Salle´, J., Gervais, L., Boumard, B., Stefanutti, M., Siudeja, K., and Bardin, A.J.
(2017). Intrinsic regulation of enteroendocrine fate by Numb. EMBO J 36,
1928–1945, e201695622–18.
Sawada, G., Ueo, H., Matsumura, T., Uchi, R., Ishibashi, M., Mima, K.,
Kurashige, J., Takahashi, Y., Akiyoshi, S., Sudo, T., et al. (2013). CHD8 is an
independent prognostic indicator that regulates Wnt/b-catenin signaling and
the cell cycle in gastric cancer. Oncol. Rep. 30, 1137–1142.
Schnetz, M.P., Bartels, C.F., Shastri, K., Balasubramanian, D., Zentner, G.E.,
Balaji, R., Zhang, X., Song, L., Wang, Z., Laframboise, T., et al. (2009).
Genomic distribution of CHD7 on chromatin tracks H3K4methylation patterns.
Genome Res. 19, 590–601.
Schnetz, M.P., Handoko, L., Akhtar-Zaidi, B., Bartels, C.F., Pereira, C.F.,
Fisher, A.G., Adams, D.J., Flicek, P., Crawford, G.E., Laframboise, T., et al.
(2010). CHD7 targets active gene enhancer elements to modulate ES cell-spe-
cific gene expression. PLoS Genet. 6, e1001023.
Schulz, Y., Freese, L., M€anz, J., Zoll, B., Vo¨lter, C., Brockmann, K.,
Bo¨gershausen, N., Becker, J., Wollnik, B., and Pauli, S. (2014a). CHARGE
and Kabuki syndromes: a phenotypic and molecular link. Hum. Mol. Genet.
23, 4396–4405.
Schulz, Y., Wehner, P., Opitz, L., Salinas-Riester, G., Bongers, E.M.H.F., van
Ravenswaaij-Arts, C.M.A., Wincent, J., Schoumans, J., Kohlhase, J.,
Borchers, A., et al. (2014b). CHD7, the gene mutated in CHARGE syndrome,
regulates genes involved in neural crest cell guidance. Hum. Genet. 133,
997–1009.
Shaw, R.L., Kohlmaier, A., Polesello, C., Veelken, C., Edgar, B.A., and Tapon,
N. (2010). The Hippo pathway regulates intestinal stem cell proliferation during
Drosophila adult midgut regeneration. Development 137, 4147–4158.
Soubeyran, P., Kowanetz, K., Szymkiewicz, I., Langdon, W.Y., and Dikic, I.
(2002). Cbl-CIN85-endophilin complex mediates ligand-induced downregula-
tion of EGF receptors. Nature 416, 183–187.
Southall, T.D., Gold, K.S., Egger, B., Davidson, C.M., Caygill, E.E., Marshall,
O.J., and Brand, A.H. (2013). Cell-type-specific profiling of gene expression
and chromatin binding without cell isolation: assaying RNA Pol II occupancy
in neural stem cells. Dev. Cell 26, 101–112.
Srinivasan, S., Armstrong, J.A., Deuring, R., Dahlsveen, I.K., McNeill, H., and
Tamkun, J.W. (2005). The Drosophila trithorax group protein Kismet facilitates
an early step in transcriptional elongation by RNA polymerase II. Development
132, 1623–1635.
Srinivasan, S., Dorighi, K.M., and Tamkun, J.W. (2008). Drosophila Kismet reg-
ulates histone H3 lysine 27 methylation and early elongation by RNA polymer-
ase II. PLoS Genet. 4, e1000217.
Staley, B.K., and Irvine, K.D. (2010). Warts and Yorkiemediate intestinal regen-
eration by influencing stem cell proliferation. Curr. Biol. 20, 1580–1587.
Tahara, T., Yamamoto, E., Madireddi, P., Suzuki, H., Maruyama, R., Chung,
W., Garriga, J., Jelinek, J., Yamano, H.O., Sugai, T., et al. (2014). Colorectal
carcinomasWith CpG island methylator Phenotype 1 frequently contain muta-
tions in chromatin regulators. Gastroenterology 146, 530–538.e5.
Talkowski, M.E., Rosenfeld, J.A., Blumenthal, I., Pillalamarri, V., Chiang, C.,
Heilbut, A., Ernst, C., Hanscom, C., Rossin, E., Lindgren, A.M., et al. (2012).
Sequencing chromosomal abnormalities reveals neurodevelopmental loci
that confer risk across diagnostic boundaries. Cell 149, 525–537.
Terriente-Fe´lix, A., Lo´pez-Varea, A., and de Celis, J.F. (2010). Identification of
genes affecting wing patterning through a loss-of-function mutagenesis
screen and characterization of med15 function during wing development.
Genetics 185, 671–684.
Terriente-Fe´lix, A., Molnar, C., Go´mez-Skarmeta, J.L., and de Celis, J.F.
(2011). A conserved function of the chromatin ATPase Kismet in the regulation
of hedgehog expression. Dev. Biol. 350, 382–392.
Thompson, B.A., Tremblay, V., Lin, G., and Bochar, D.A. (2008). CHD8 is an
ATP-dependent chromatin remodeling factor that regulates beta-catenin
target genes. Mol. Cell. Biol. 28, 3894–3904.
Tian, A., and Jiang, J. (2014). Intestinal epithelium-derived BMP controls stem
cell self-renewal in Drosophila adult midgut. Elife 3, e01857.
Tian, A., Shi, Q., Jiang, A., Li, S., Wang, B., and Jiang, J. (2015). Injury-stimu-
latedHedgehog signaling promotes regenerative proliferation of Drosophila in-
testinal stem cells. J. Cell Biol. 208, 807–819.
Tian, A., Wang, B., and Jiang, J. (2017). Injury-stimulated and self-restrained
BMP signaling dynamically regulates stem cell pool size during Drosophila
midgut regeneration. Proc. Natl. Acad. Sci. USA 114, E2699–E2708.
Tie, F., Banerjee, R., Conrad, P.A., Scacheri, P.C., and Harte, P.J. (2012).
Histone demethylase UTX and chromatin remodeler BRM bind directly to
CBP and modulate acetylation of histone H3 lysine 27. Mol. Cell. Biol. 32,
2323–2334.
van Steensel, B., and Henikoff, S. (2000). Identification of in vivo DNA targets of
chromatin proteins using tethered dammethyltransferase. Nat. Biotechnol. 18,
424–428.Vissers, L.E.L.M., van Ravenswaaij, C.M.A., Admiraal, R., Hurst, J.A., de Vries,
B.B.A., Janssen, I.M., van der Vliet, W.A., Huys, E.H.L.P.G., de Jong, P.J.,
Hamel, B.C.J., et al. (2004). Mutations in a new member of the chromodomain
gene family cause CHARGE syndrome. Nat. Genet. 36, 955–957.
Wang, C., Guo, X., and Xi, R. (2014). EGFR and Notch signaling respectively
regulate proliferative activity and multiple cell lineage differentiation of
Drosophila gastric stem cells. Cell Res. 24, 610–627.
Xu, N., Wang, S.Q., Tan, D., Gao, Y., Lin, G., and Xi, R. (2011). EGFR, Wingless
and JAK/STAT signaling cooperatively maintain Drosophila intestinal stem
cells. Dev. Biol. 354, 31–43.
Zabidi, M.A., Arnold, C.D., Schernhuber, K., Pagani, M., Rath, M., Frank, O.,
and Stark, A. (2015). Enhancer-core-promotor specificity separates develop-
mental and housekeeping gene regulation. Nature 518, 556–559.
Zeng, X., Chauhan, C., and Hou, S.X. (2010). Characterization of midgut stem
cell- and enteroblast-specific Gal4 lines in drosophila. Genesis 48, 607–611.
Zielke, N., Korzelius, J., van Straaten, M., Bender, K., Schuhknecht, G.F.P.,
Dutta, D., Xiang, J., and Edgar, B.A. (2014). Fly-FUCCI: a versatile tool for
studying cell proliferation in complex tissues. Cell Rep. 7, 588–598.
Zink, D., and Paro, R. (1995). Drosophila Polycomb-group regulated chromatin
inhibits the accessibility of a trans-activator to its target DNA. EMBO J. 14,
5660–5671.Developmental Cell 49, 556–573, May 20, 2019 573
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse anti-Delta ECD (1:2000) DSHB Cat# c594.9b;
RRID: AB_528194
Mouse anti-Notch ECD (1:100) DSHB Cat# c458.2h;
RRID: AB_528408
Mouse anti-Prospero (MR1A; 1:1000) DSHB RRID: AB_528440
Chicken anti-GFP (1:2000) Abcam Cat# ab13970; RRID: AB_300798
Goat anti-ßGAL (1:500) Biogenesis Cat# 466–1409
Rabbit anti-Pdm1 (1:1000) Gift from X. Yang,
Zhejiang University, China
RRID: AB_2570215
Rabbit anti-PH3 (1:1000) Millipore Millipore Cat# 06-570; RRID: AB_310177
Goat anti-Kismet DK20 (1:500) Santa Cruz sc-15848; RRID: AB_672122
Rabbit anti-Utx, (1:500) Gift from A. Shilatifard,
Northwestern University Feinberg School
of Medicine
RRID: AB_2567973
Rabbit anti-Trr (1:500) Gift from A. Shilatifard,
Northwestern University Feinberg School
of Medicine
RRID: AB_2568870
Rabbit anti-Lpt (1:500) Gift from A. Shilatifard,
Northwestern University Feinberg School
of Medicine
RRID: AB_2568872
Rabbit anti-H3K4me1 (1:500) Gift from A. Shilatifard,
Northwestern University Feinberg School
of Medicine
N/A
Rabbit anti-dpERK (1:200) Cell Signaling Technology Cat# 4377; RRID: AB_331775
Rabbit anti-H3K27me3 (1:500) Diagenode Cat# C15410195; RRID: AB_2753161
Rabbit anti-H3K27ac (1:2000) Abcam Cat# ab4729; RRID: AB_2118291
Mouse anti-EGFR (1:100) Sigma Cat# E2906; RRID: AB_609900
Rabbit anti-DH31 (1:500), Gift from J.A. Veenstra,
Universite´ de Bordeaux
RRID: AB_2569126
Rabbit anti-LTK2 (1:1000) Gift from J.A. Veenstra,
Universite´ de Bordeaux
N/A
Chemicals, Peptides, and Recombinant Proteins
Alexa 647-conjugated phalloidin (1:100) LifeTechnologies Cat# A22287: RRID: AB_2620155
Quick ligase NEB Cat# M2200S
RNase A Sigma Cat# R6513-50MG
T4 DNA ligase NEB Cat# B0202S
DpnI NEB Cat#R0176L
DpnII NEB Cat#R0543L
Sau3AI NEB Cat# R0169L
PCR buffer MyTaq HS Bioline Cat# BIO-21111
AlwI NEB Cat# R0513S
Klenow fragment NEB Cat# 210S
T4 polynucleotide kinase NEB Cat# M0201S
Elastase Sigma Cat# E0258-5MG
Critical Commercial Assays
Qiaquick PCR Purification kit Qiagen Cat# 28104
QIAmp DNA Micro Kit Qiagen Cat# 56304
Arcturus PicoPure RNA Isolation Kit ThermoScientific Cat# KIT0202
(Continued on next page)
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RNase-Free DNase Set Qiagen Cat# 79254
Arcturus RiboAmp HS PLUS Kit ThermoScientific Cat# KIT0525
Deposited Data
Lists of expressed genes and cell type-
specific genes were generated from
published RNAseq data in the gut
Dutta et al., 2015 http://flygutseq.buchonlab.com/resources
Experimental Models: Organisms/Strains
Drosophila: FRT40A kis10D26 This study, Institut Curie Paris. N/A
Drosophila: UAS-LT3-NDam Southall et al., 2013 N/A
Drosophila: kis1 Daubresse et al., 1999 Cat# 431, RRID:BDSC_431
Drosophila: UAS-kis-RNAi #36597 BDSC, (Perkins et al., 2015) Cat# 36597, RRID:BDSC_36597
Drosophila: UAS-kismet RNAi #34908 BDSC, (Perkins et al., 2015) BDSC Cat# 34908, RRID:BDSC_34908)
Drosophila: UAS-EGFRDN BDSC (Buff et al., 1998) BDSC Cat# 5364, RRID:BDSC_5364
Drosophila: UAS-lpt-RNAi BDSC, (Perkins et al., 2015) BDSC Cat# 25994, RRID:BDSC_25994
Drosophila: UAS-trr-RNAi BDSC, (Perkins et al., 2015) BDSC Cat# 29563, RRID:BDSC_29563
Drosophila: UAS-utx-RNAi BDSC, (Perkins et al., 2015) BDSC Cat# 34076, RRID:BDSC_34076
Drosophila: FR82B trxE2 BDSC (Gindhart and Kaufman, 1995) BDSC Cat# 24160, RRID:BDSC_24160
Drosophila: FR19A trrB BDSC (Haelterman et al., 2014) BDSC Cat# 57138, RRID:BDSC_57138
Drosophila: UAS-bskDN BDSC (Adachi-Yamada et al., 1999) BDSC Cat# 6409, RRID:BDSC_6409
Drosophila: UAS-yki-RNAi BDSC, (Perkins et al., 2015) BDSC Cat# 34067, RRID:BDSC_34067
Drosophila: UAS-InRDN Gift to BDSC by Exelixis, Inc. BDSC Cat# 8253, RRID:BDSC_8253
Drosophila: UAS-domeRNAi BDSC, (Perkins et al., 2015) BDSC Cat# 34618, RRID:BDSC_34618
Drosophila: UAS-ash1-RNAi # 31050 BDSC, (Perkins et al., 2015) BDSC Cat# 31050, RRID:BDSC_31050
Drosophila: UAS-ash1-RNAi # 36130 BDSC, (Perkins et al., 2015) BDSC Cat# 36130, RRID:BDSC_36130
Drosophila: UAS-brm-RNAi BDSC, (Perkins et al., 2015) BDSC Cat# 31712, RRID:BDSC_31712
Drosophila: UAS-Cbl-RNAi BDSC, (Perkins et al., 2015) BDSC Cat# 27500, RRID:BDSC_27500
Drosophila: UAS-GFP-E2f1-230, UAS-
mRFP-CycB1-266
BDSC (Zielke et al., 2014) BDSC Cat# 55118, RRID:BDSC_55118
Drosophila: 10XSTAT92E-GFP BDSC (Ekas et al., 2006) BDSC Cat# 26198, RRID:BDSC_26198
Drosophila: CycE-lacZ BDSC
Gift by Helena Richardson, Peter
MacCallum Cancer Centre to BDSC
BDSC Cat# 30722, RRID:BDSC_30722
Drosophila: UAS-set1-RNAi VDRC, (Dietzl et al., 2007) Cat# 40682
Drosophila: UAS-cic-RNAi VDRC, (Dietzl et al., 2007) Cat# 103805
Drosophila: FRT40A kisLM27 Gift from D.R. Marenda,
Drexel University.
N/A
Drosophila: FRT40A kisEC1 Gift from D.R. Marenda N/A
Drosophila: NRE-LacZ Furriols and Bray, 2001 N/A
Drosophila: UAS-Notchcdc10 Brennan et al., 1999 N/A
Drosophila: UAS-LT3-NDam-RNAPol II Southall et al., 2013 N/A
Drosophila: UAS-LT3-Dam-Pc Marshall and Brand, 2017 N/A
Drosophila: UAS-LT3-Dam-HP1a Marshall and Brand, 2017 N/A
Drosophila: UAS-LT3-Dam-Brm Marshall and Brand, 2017 N/A
Drosophila: UAS-LT3-Dam-H1 Marshall and Brand, 2017 N/A
Drosophila: UAS-cicHA Jin et al., 2015 N/A
Drosophila: pucE69-LacZ Gift from N.Tapon, Francis Crick Institute,
London
N/A
Drosophila: Upd-LacZ Gift from B.A. Edgar,
Huntsman Cancer Institute, Utah
N/A
Drosophila: Upd3.1-LacZ Gift from B.A. Edgar,
Huntsman Cancer Institute, Utah
N/A
(Continued on next page)
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Drosophila: UAS-Cbl-L Gift from L.M. Pai,
Chang Gung University, Taiwan
N/A
Drosophila: UAS-Cbl-S Gift from L.M. Pai,
Chang Gung University, Taiwan
N/A
Drosophila: NRE-GAL4 ; tubGAL80ts
UAS-GFP
Zeng et al., 2010 N/A
Drosophila: esg-GAL4, tubGAL80ts
UAS-GFP
Jiang et al., 2009 N/A
Drosophila: esg-GAL4 UAS-GFP; Su(H)
GBE-GAL80
tubGAL80ts
Wang et al., 2014 N/A
Drosophila: MyoIAGAL4; tubGAL80ts
UAS-GFP
Jiang et al., 2009 N/A
Drosophila: prosvoila-Gal4, tub-Gal80ts Balakireva et al., 1998 N/A
Drosophila: w P[hs-FLP] P[pTub-GAL4]
P[UAS-nlsGFP]
Bardin et al., 2010 N/A
Drosophila: FRT40A P[pTub-GAL80] Bardin et al., 2010 N/A
Drosophila: FRT82B P[pTub-GAL80] Bardin et al., 2010 N/A
Drosophila: w P[hs-FLP]; FRT40A
P[pTub-GAL80]; Drosophila: P[UAS-RFP],
P[pTub-GAL4]
This paper, Institut Curie, Paris. N/A
Drosophila: hsflp122 P[pTub-GAL80]
FRT19A; P[pAct-GAL4] P[UASGFP]
Lin et al., 2008 N/A
Recombinant DNA
Drosophila BAC: (P[acman] BAC
CH322-128O7)
BACPAC Resources Center CH322-128O7
Drosophila BAC: (P[acman] BAC
CH321-35E09)
BACPAC Resources Center CH321-35E9
Plasmid: kislocus-FLP This paper, Institut Curie, Paris. N/A
Plasmid: R6kam-hNGFP Gift from A. A. Hyman,
Max Planck Institute, Dresden.
N/A
Plasmid: UAS- KisS-Flag This paper, Institut Curie, Paris. N/A
Plasmid: UAS-KisL-His-Flag This paper, Institut Curie, Paris. N/A
Plasmid: UAS-kis-K2060R-His-Flag This paper, Institut Curie, Paris. N/A
Plasmid: pUASTattB-LT3-NDam Southall et al., 2013 N/A
Plasmid: UAS-LT3-Dam-Kis This paper, Institut Curie, Paris. N/A
Plasmid: UAS-LT3-Dam-Trr This paper, Institut Curie, Paris. N/A
Software and Algorithms
Prism 7 GraphPad Software RRID:SCR_002798
FIJI https://fiji.sc N/A
Damidseq_pipeline Marshall and Brand, 2015 https://owenjm.github.io/
bowtie2 Langmead and Salzberg, 2012 http://bowtie-bio.sourceforge.net/bowtie2/
index.shtml
bedtools Quinlan and Hall, 2010 https://bedtools.readthedocs.io/en/latest/
index.html
DESeq2 Love et al., 2014 https://bioconductor.org/packages/
release/bioc/html/DESeq2.html
deepTools plotHeatmap Ramı´rez et al., 2014 https://deeptools.readthedocs.io/en/
develop/content/tools/plotHeatmap.html
polii.gene.call Marshall and Brand, 2015 https://owenjm.github.io/
Galaxy Afgan et al., 2016 https://usegalaxy.org
IPython https://ipython.org
Galaxy workflow IPython notebooks and UMAP code used in
this study - Institut Curie Paris
https://github.com/bardin-lab/kismet-
analysis
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Allison
Bardin (allison.bardin@curie.fr).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Flies were kept in yeasted tubes at 25C unless mentioned. The following fly stocks were used in this study: FRT40A kis10D26 (from
C.P., F.S., A.J.B., unpublished genetic screen), kis1 (#431), UAS-kis-RNAi (#36597) for Figures 2L–2P, 2R, S2A–S2E0, S2G, S2I, S2K,
and S2M and UAS-kismet RNAi #34908 for Figures 2M, 2N, 2Q, 3I, 3J, 7B, 7F, S6Q, S6R, and S6T and for kismet knockdown RNA-
seq condition), UAS-lpt-RNAi (#25994), UAS-trr-RNAi (#29563), UAS-utx-RNAi (#34076), FR82B trxE2 (#24160), FRT19A trrB encod-
ing a putative truncated 512-aa protein (#57138), UAS-EGFRDN (#5364), UAS-bskDN (#6409), UAS-yki-RNAi (#34067), UAS-InRDN
(#8253), UAS-domeRNAi (#34618), UAS-ash1-RNAi (#31050 and #36130), UAS-brm-RNAi (#31712), UAS-Cbl-RNAi (#27500),
UAS-GFP-E2F1-230, UAS-mRFP-CycB1-266 (#55118), 10XSTAT92E-GFP (#26198), CycE-lacZ (#30722), (From the Bloomington
Drosophila Stock Center, BDSC), UAS-set1-RNAi (#40682), UAS-cic-RNAi (#103805) (From the Vienna Drosophila RNAi Center,
VDRC), kisLM27 and kisEC1 (Melicharek et al., 2008),NRE-LacZ (Furriols and Bray, 2001),Nintra:UAS-Notchcdc10 is a truncated active
version of intracellular Notch, (Brennan et al., 1999),UAS-LT3-NDam andUAS-LT3-NDam-RNAPol II (Southall et al., 2013)UAS-LT3-
Dam-Pc, UAS-LT3-Dam-HP1a, UAS-LT3-Dam-Brm and UAS-LT3-Dam-H1 (Marshall and Brand, 2017), UAS-cicHA (Jin et al., 2015),
pucE69-LacZ (gift from N.Tapon), Upd-LacZ and Upd3.1-LacZ (gift from B. Edgar), UAS-Cbl-L and UAS-Cbl-S (gift from L.M. Pai).
The following Gal4 drivers were used: NRE-GAL4 ; tubGAL80ts UAS-GFP (NREts) (Zeng et al., 2010), esg-GAL4, tubGAL80ts UAS-
GFP (esgts) (Jiang et al., 2009), esg-GAL4 UAS-GFP; Su(H)GBE-GAL80 tubGAL80ts (esgts, NREGAL80) (Wang et al., 2014),MyoIA-
GAL4; tubGAL80ts UAS-GFP (Myo1Ats) (Jiang et al., 2009). prosvoila-Gal4, tub-Gal80ts (prosts) (Balakireva et al., 1998).
METHOD DETAILS
Generation of Transgenic Flies
kislocus construct containing 524 bp upstream to 12 kb downstream of the kis gene was generated starting from Drosophila BAC
(P[acman] BAC CH321-35E09) that was further altered by recombineering to reduce the genomic size and to add a FLAP
cassette N-terminally (amplified from the plasmid R6kam-hNGFP; kindly provided by T. Hyman). The FLAP cassette is
composed of green fluorescent protein (GFP), S- and Flag-affinity tags separated by PreScission- and TEV- protease sites.
Transgenic flies were generated at Bestgene, Inc. by injection of attP-9AVK00013. To generate UAS-kisL and UAS-kisS trans-
genic flies, kis-RA and kis-RB cDNA were respectively amplified from a midgut library and then inserted into the pUASPattB
plasmid and tagged with both a 6xHIS N-terminal and a FLAG C-terminal cassette for kis-RA and only by a FLAG C-terminal
cassette for kis-RB. Transgenic flies were generated at Bestgene, Inc. by injection of attP-3BVK00033 embryos. The mutation
of Chd7 K999R, a residue in the highly conserved ATP binding motif of SNF2 superfamily proteins, was shown to prevent its
ATPase catalytic activity (Bouazoune and Kingston, 2012). We therefore made the equivalent K2060R mutation in Kismet coding
sequence. To generate UAS-kis-K2060R transgenic flies, the mutation G>A at 2060th codon was inserted into the pUASP-
6His_kis-PA_Flag BAC plasmid by recombineering using the rpsl/neo positive and counterselection system. The final plasmid
was tagged with both a 6xHIS N-terminal and a FLAG C-terminal cassettes. Transgenic flies were generated at Bestgene,
Inc. by injection of attP-3B-VK00033 embryos. To generate UAS-Dam-kis transgenic, UAST-mCherry-NDam-Myc sequences
amplified from the pUASTattB-LT3-NDam plasmid (Southall et al., 2013) were inserted N-terminally to kis-RA cDNA attB con-
taining vector followed by injection by Bestgene, Inc of attP2 embryos. To generate UAS-Dam-trr transgenic, the trr sequence
from the ATG to stop codon was obtained starting from Drosophila BAC CH322-128O7 that was further altered by recombin-
eering to reduce the genomic size and amplified before insertion C-terminally to Myc into UAST-mCherry-NDam-Myc plasmid
by Gibson Cloning method followed by injection by Bestgene, Inc of P{CaryP}attP2 embryos with the plasmid together with a
phiC31 integrase helper plasmid pBS130 as an integrase source.
Clonal Analysis and Gal4 Expression
Cloneswere generatedwith theMosaic Analysis with Repressible Cell Marker (MARCM) technique (Lee and Luo, 1999). The following
fly stocks were used for MARCM: hsflp122 P[pTub-GAL80] FRT19A; P[pAct-GAL4] (Lin et al., 2008) to produce GFP marked clones
on the X chromosome and P[UASGFP]w P[hs-FLP] P[pTub-GAL4] P[UAS-nlsGFP] associated with either FRT40A P[pTub-GAL80] or
FRT82B P[pTub-GAL80] to produce GFPmarked clones on the second or the third chromosome respectively, w P[hs-FLP]; FRT40A
P[pTub-GAL80]; P[UAS-RFP], P[pTub-GAL4] to produce RFP marked clones on the second chromosome and w P[hs-FLP]; FRT40A
P[pTub-GAL80]; P[pTub-GAL4] to produce clones expressing UAS-GFP-E2f1-230, UAS-mRFP-CycB1-266 FUCCI system. MARCM
Clones were induced with a heat shock (35 min at 36.5C) on 3-day-old adult females and were dissected 5, 9, 10, 12 or 30 days
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MARCMts clones were generated using the following stock: w P[hs-FLP] P[pTub-GAL4] P[UAS-nlsGFP]; FRT40A P[pTub-GAL80];
P[pTub-GAL80ts]. Crosses were maintained at 18C, before and after 35 minutes heat shock clone induction at 36.5C in 3-day-old
adult females. 10 days AHS, temperature was shifted to 29C for 3 days before dissection to allow transgenes expression (UAS-GFP
and UAS-NAct).
For temporal cell type-specific expression of kismet RNAi we used the temperature sensitive inducible UAS-GAL4/GAL80ts sys-
tem. Crosses and adults were kept at 18C, the GAL80 permissive temperature. 3-day-old flies were shifted to 29C for 2, 3 or
10 days to induce RNAi expression.
Immunofluorescence and Imaging
As described previously (Bardin et al., 2010), adult female midguts were dissected in PBS and then fixed at room temperature (RT)
for 2 hours in 4% paraformaldehyde. Gut were trimmed and incubated in PBS 50% glycerol for 30 minutes before equilibration in
PBS 0.1% Triton X-100 (PBT) to clean the lumen. For anti-NotchECD staining, guts were fixed for 15min in 4% formaldehyde/heptane
followed methanol treatment and rehydration in PBT as described in (Lin et al., 2008). Fixed samples were then washed in PBT for
at least 30 min before addition of primary antibodies (overnight at 4C or 3-5 hours at RT). After at least 30 min wash, secondary
antibodies were incubated 3-5 hours before DAPI staining (1 mg/ml) and mounted in 4% N-propyl-galate, 80% glycerol. Polytene
immunostainings were performed on L3 larvae salivary glands chromosomes as described in (Zink and Paro, 1995). Salivary glands
were fixed in droplet of 45%acetic acid for 3min. The coverslip was placed onto a poly-L-lysine coated slide and tapped using the tip
of a pencil to spread the chromosomes. The quality of the preparations was checked under phase contrast microscope. Slides
were next snap-frozen in liquid nitrogen, and coverslip removed. Slides were immediately put in PBS before replacement by blocking
solution (1% BSA, 0.5% Triton X100 in PBS) for 1 hour at RT. 50ml of primary antibody in blocking solution was placed onto the chro-
mosome spreads in a humid chamber (1 hour at 4C). Slides were washed in PBS 0.5% triton for 15 minutes. Secondary antibodies
were incubated for 1 hour before DAPI staining (1ı`g/ml) and mounted in 4% N-propyl-galate, 80% glycerol.
The following primary antibodies were used: anti-Delta ECD C594.9B (mouse,1:2000, Developmental Studies Hybridoma Bank
(DSHB)); anti-GFP (chicken, 1:2000, Abcam), anti-DsRed (rabbit, 1;1000, Clontech), anti-Sanpodo (rabbit, 1:1000; J. Skeath), anti-
Notch ECD C458.2H (mouse, 1:100, DSHB), anti-ßGAL (goat, 1:500; Biogenesis), anti-Prospero (mouse, MR1A; 1:1000; DSHB),
anti-Pdm1 (rabbit, 1:1000; X. Yang), anti-PH3 (rabbit, 1:1000; Millipore), anti-Kismet DK20 (goat, 1:500; Santa Cruz), anti-Utx,
anti-Trr, anti-Lpt and anti-H3K4me1 (Rabbit, 1:500 (Herz et al., 2012)), anti-dpERK (Rabbit, 1:200; Cell Signaling Technology),
anti-H3K27me3 (Rabbit, 1:500; Diagenode), anti-H3K27ac (Rabbit, 1:2000; Abcam), anti-EGFR (Mouse, 1:100, Sigma), anti-DH31
(Rabbit, 1:500, J.A Veenstra), anti-LTK2 (Rabbit, 1:1000 J.A Veenstra) and Alexa 647-conjugated phalloidin (1:100, LifeTechnologies).
Imaging was performed using Zeiss LSM700 and LSM780 confocal microscopes at the Curie Institute imaging facility with serial
optical sections taken at 1 to 1.5-mm intervals (512X512 or 1024X1024) using 20X or 40X oil objectives through the whole-mounted
posterior midguts. Representative images are shown in all panels. Super-resolution image was performed with a Structured Imaging
Microscope (OMX v3 from Applied Precision-GE Healthcare), equipped with 3 EMCCD, Evolve cameras (Photometrics).
DamID-Seq Analysis
In DamID, the fusion of Dam methyl transferase to a DNA associated protein allows the methylation of surrounding GATC sites of
DNA, which can be specifically sequenced (Choksi et al., 2006; van Steensel and Henikoff, 2000). In targeted DamID-Seq, cell
type-specific low level expression is achieved, thereby allowing in vivo mapping of chromatin associated factors (Southall
et al., 2013).
Using the damidseq_pipeline (Marshall and Brand, 2015) reads in fastq files were aligned to theDrosophila melanogaster reference
genome version 6 using bowtie2 (Langmead and Salzberg, 2012) and alignments were extended to 300 nucleotides or the first GATC
site, whichever occurred first.
For all GATC sites in mappable regions read coverage was counted using bedtools coverage (Quinlan and Hall, 2010). GATC sites
with fewer than 5 counts on average were discarded. The remaining GATC sites were split into control counts and DamID fusion
counts and tested for statistically significant differences using DESeq2 (Love et al., 2014), which also estimates a variance stabilized
log2 fold enrichment values for each GATC site.
Peaks were called by merging 2 or more consecutive significant GATC sites (adjusted p-value < 0.01, log2 fold change > 0). Genes
were classified as bound by a protein if 2 consecutive GATC sites within the gene body were occupied with an adjusted
p-value < 0.01.
Metaplots were produced using deepTools plotHeatmap (Ramı´rez et al., 2014) using the DESeq2 output that was converted into
bigwig files. Developmental and housekeeping S2 cells enhancers are defined in (Zabidi et al., 2015). Lists of expressed genes and
cell type-specific genes were generated from published RNAseq data in the gut (Dutta et al., 2015). All genes with rpkm >1 in the ISC
were considered as significantly expressed. Lists of genes enriched in each cell type (ISC, EC, EE) were generated by applying the
following criteria: (1) the gene rpkm in one specific cell type is at least 2 times higher than the rpkm in each of the other cell types, (2)
the gene rpkm in each other cell type is <2. Lists of EE-enriched genes and EC-enriched genes were merged to generate the list of
differentiated cell types-enriched genes.
For the calculation of distribution of Kismet bound GATC sites in the genome in Figure 4A theDrosophila gene annotation GTF was
downloaded from flybase version 6.13 (Gramates et al., 2017). The GTF file was filtered to retain only 30UTR coding, 50UTR coding,
exon and gene features. The file was then split into a single file per genomic feature and overlapping features were merged usinge5 Developmental Cell 49, 556–573.e1–e6, May 20, 2019
bedtools. Using bedtools subtract, exonic regions were subtracted from genic regions to obtain intronic regions, and exonic regions
were subtracted from overlapping 30UTR and 50UTR coding regions. Significantly bound GATC sites were classified as belonging to
one of these regions using bedtools intersect.
RNA Pol II occupancy was determined by considering mean ratios (Dam-RNA Pol II/Dam-only) across annotated transcripts using
‘‘polii.gene.call’’ script and false discovery rates (FDR) were assigned (Marshall and Brand, 2015; Southall et al., 2013). Genes with an
FDR < 0.01 were used as genes active in ISC (Figures 4J and 6D).
All analysis has been done on Galaxy (Afgan et al., 2016).
A 2D UMAP embedding (McInnes et al., 2018) was created from the log2 values estimated by DESeq2. To evaluate the embedding
we plotted the log2 value for each GATC and each chromatin protein in the UMAP coordinates. We explored effect of varying the
n_neighbors, min_dist, n_components and metric parameter and note that varying the parameters results in very similar maps.
The parameters used are n_neighbors=30, min_dist=0.0, n_components=2, random_state=42, metric=’canberra’.
RNAseq Analysis
For transcriptome profiling of sorted ISC, 3-day-old females with either UAS-GFP with UAS-white-RNAi (control), or with UAS-kis
RNAi or withUAS-trr-RNAi under the control of esgts NREGal80were shifted from 18C to 29C for 2 days to induce RNAi expression.
For each biological replicate (n=3 for control, n=4 for kis-RNAi, n=3 for trr-RNAi) midguts from 100 females were dissected in PBS
before FACS sorting isolation of ISCGFP+ cells followed byRNA isolation and amplification as described in (Dutta et al., 2013). Reads
were quasi-mapped against the Drosophila reference transcriptome fasta (Flybase, release 6.13) using Salmon (Patro et al., 2017).
Differential gene expression testing was performed using tximportData, RUVseq (Risso et al., 2014) and DESeq2. Genes with an
adjusted p-value < 0.01 were considered differentially expressed. All analysis has been done on Galaxy (Afgan et al., 2016).
QUANTIFICATION AND STATISTICAL ANALYSIS
Image acquisition was followed by data processing with Fiji software and assembled using Adobe Photoshop. Images were pro-
cessed with a median filter of 1-pixel width before applying Z-stack max projections. All quantification of clonal analysis was limited
to the posterior midgut and only clones containing two or more cells (stem cell clones) were scored except for Figure S3J where 1 cell
clones were included. Contiguous cells (GFP+ or RFP+) were considered as part of one discrete clone for quantifications. All graphs
are scatterplots of raw data to present the full distribution of values observed and all statistical analysis were performed using
Prism software. PH3+ cells number per gut was evaluated on the entire midgut (Figure 2D). In Figures 2J and 5H, Kis and Utx staining
intensity were quantified within the posterior midgut. The largest nuclear plane for each cell type (esg+ ISC/EB, esg-diploid EE and
esg- polyploid Ecs) was determined manually and the average fluorescent intensities of Kismet, Utx and DAPI were calculated with
Fiji for these planes. In Figures 5I and 5J, EGFR staining intensity in esg+ cells was quantified per square region within each posterior
midgut. The largest plane for each esg+ cell was determined manually in order to measure the cell area and mean fluorescent
EGFR intensity with Fiji software and to calculate total EGFR intensity. Statistical analysis were performed using the Graphpad Prism
softaware and significance calculated by either two-tailed Mann-Whitney or chi2 statistical tests with ns for non-significant, * for
p<0.05, ** for p<0.01, *** for p<0.001 and ****p<0.0001.
DATA AND SOFTWARE AVAILABILITY
Galaxy workflows, IPython notebooks and UMAP code used in the analysis are available at https://github.com/bardin-lab/kismet-
analysis. DamID-Seq and RNA-Seq data have been deposited in the Gene Expression Omnibus (GEO). The accession number
for DamID-Seq and RNA-Seq data reported in this paper isGSE128941.Developmental Cell 49, 556–573.e1–e6, May 20, 2019 e6
